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Response to Reviewers: Responses to the comments of Reviewer 1
Dear Reviewer,
Thank you for your thoughtful and constructive comments.
We addressed all your comments and further experimentation was performed,
according to your advice.
Specifically:
Comment 1.The paper would be much strengthened by further experiments directly
addressing JNK in mediating CPD effects (e.g. inhibit JNK and then determine
photolyase effect with and without UV), without this critical experiment, the manuscript
is, in my opinion, too correlative.
We agree with your assertion and carried out the proposed experiment. The results are
included into the revised Figure 4 (see lines 330-340, on page 15 of the revised
manuscript).
Comment 2.Is it possible that certain genes (e.g. their promoters or enhancers) may be
particularly vulnerable to UV-induced CPD formation? If so, then these genes may be
down-regulated directly by UV rather than through a damage-response pathway such
as JNK. (alternatively a gene's expression might be upregulated if an inhibitory gene's
expression were CPD-prone).
We agree that regulatory regions of selected genes might be directly vulnarable to
UVB, therefore we included this potential in the manuscript and added background
material to the revised manuscript and propounded an experimental procedure to
appropriately support this issue (see lines 483-491, on pages 21-22 of the revised
manuscript).
Comment 3.It seems odd that the figure legends are embedded right in the text rather
than as a separate section.
We corrected this error. The figure legends are now in a separate section at the end of
the revised manuscript.
Comment 4.Do the data exclude a role for gene regulation by 6,4-photoproducts?
We have added a new section to the revised manuscript in which we provide additional
information related to the contribution of 6-4 photoproducts to UVB-induced changes of
gene expression (see lines 368-379, on page 17 of the revised manuscript).
Comment 5.The role of p53 should also be examined in CPD-induced gene expression
changes.
We agree, so we have inserted background material to provide additional information
about the role of p53 in UVB-induced cellular stress responses (see lines 395-404, on
page 18 of the revised manuscript).
Response to the comment of Reviewer 2
Dear Reviewer,
We appreciate your comment and following your suggestion we prepared a separate
conclusion section.
Comment 1.The major short-coming, which is mostly editorial, is coming from the lack
of a separate conclusion section. The last paragraph, which effectively serves as a
conclusion, needs to be expanded and be placed in line with the abstract.
We have added a separate conclusion section to provide additional context to the
revised manuscript (see lines 493-511, on page 22 of the revised manuscript).
Additional Information:
Question Response
Financial Disclosure
Please describe all sources of funding
This work was supported by National Institutes of Health (grant number R01NS029331
and R42HL87688 to K.K.; R01AI50484 and R21DE019059 to D.W.), the Hungarian
Scientific Research Fund (OTKA K105872 to É.R., OTKA K108421 to A.SZ.) and
National Research Grant (TÁMOP-4.2.2-A-11/1/KONV-2012-0031 to É.R.).
The funders had no role in study design, data collection and analysis, decision to
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that have supported your work. A
complete funding statement should do the
following:
Include grant numbers and the URLs of
any funder's website. Use the full name,
not acronyms, of funding institutions, and
use initials to identify authors who
received the funding.
Describe the role of any sponsors or
funders in the study design, data
collection and analysis, decision to
publish, or preparation of the manuscript.
If they had no role in any of the above,
include this sentence at the end of your
statement: "The funders had no role in
study design, data collection and analysis,
decision to publish, or preparation of the
manuscript."
If the study was unfunded, provide a
statement that clearly indicates this, for
example: "The author(s) received no
specific funding for this work."
* typeset
publish, or preparation of the manuscript."
Competing Interests
You are responsible for recognizing and
disclosing on behalf of all authors any
competing interest that could be
perceived to bias their work,
acknowledging all financial support and
any other relevant financial or non-
financial competing interests.
Do any authors of this manuscript have
competing interests (as described in the
PLOS Policy on Declaration and
Evaluation of Competing Interests)?
If yes, please provide details about any
and all competing interests in the box
below. Your response should begin with
this statement: I have read the journal's
policy and the authors of this manuscript
have the following competing interests:
If no authors have any competing
interests to declare, please enter this
statement in the box: "The authors have
declared that no competing interests
exist."
I have read the journal's policy and the authors of this manuscript have the following
competing interests: Katalin Karikó and Drew Weissman hold patents for the use of
nucleoside-modified mRNA as a therapeutic protein delivery platform. They have also
formed a small biotech company, RNARx, that received funding from the National
Institutes of Health (R42HL87688) to explore the use of nucleoside-modified mRNA for
transient gene therapy.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
* typeset
Ethics Statement
You must provide an ethics statement if
your study involved human participants,
specimens or tissue samples, or
vertebrate animals, embryos or tissues.
All information entered here should also
be included in the Methods section of your
manuscript. Please write "N/A" if your
study does not require an ethics
statement.
Human Subject Research (involved
human participants and/or tissue)
All research involving human participants
must have been approved by the authors'
Institutional Review Board (IRB) or an
equivalent committee, and all clinical
investigation must have been conducted
according to the principles expressed in
the Declaration of Helsinki. Informed
consent, written or oral, should also have
been obtained from the participants. If no
consent was given, the reason must be
explained (e.g. the data were analyzed
anonymously) and reported. The form of
consent (written/oral), or reason for lack of
consent, should be indicated in the
Methods section of your manuscript.
Please enter the name of the IRB or
Ethics Committee that approved this study
in the space below. Include the approval
number and/or a statement indicating
approval of this research.
Animal Research (involved vertebrate
animals, embryos or tissues)
All animal work must have been
conducted according to relevant national
and international guidelines. If your study
involved non-human primates, you must
provide details regarding animal welfare
and steps taken to ameliorate suffering;
this is in accordance with the
recommendations of the Weatherall
report, "The use of non-human primates in
research." The relevant guidelines
followed and the committee that approved
the study should be identified in the ethics
statement.
N/A
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If anesthesia, euthanasia or any kind of
animal sacrifice is part of the study,
please include briefly in your statement
which substances and/or methods were
applied.
Please enter the name of your Institutional
Animal Care and Use Committee (IACUC)
or other relevant ethics board, and
indicate whether they approved this
research or granted a formal waiver of
ethical approval. Also include an approval
number if one was obtained.
Field Permit
Please indicate the name of the institution
or the relevant body that granted
permission.
Data Availability
PLOS journals require authors to make all
data underlying the findings described in
their manuscript fully available, without
restriction and from the time of
publication, with only rare exceptions to
address legal and ethical concerns (see
the PLOS Data Policy and FAQ for further
details). When submitting a manuscript,
authors must provide a Data Availability
Statement that describes where the data
underlying their manuscript can be found.
Your answers to the following constitute
your statement about data availability and
will be included with the article in the
event of publication. Please note that
simply stating ‘data available on request
from the author’ is not acceptable. If,
however, your data are only available
upon request from the author(s), you must
answer “No” to the first question below,
and explain your exceptional situation in
the text box provided.
Do the authors confirm that all data
underlying the findings described in their
manuscript are fully available without
restriction?
Yes - all data are fully available without restriction
Please describe where your data may be
found, writing in full sentences. Your
answers should be entered into the box
below and will be published in the form
you provide them, if your manuscript is
accepted. If you are copying our sample
text below, please ensure you replace any
instances of XXX with the appropriate
All relevant data are within the paper and its Supporting Information files.
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details.
If your data are all contained within the
paper and/or Supporting Information files,
please state this in your answer below.
For example, “All relevant data are within
the paper and its Supporting Information
files.”
If your data are held or will be held in a
public repository, include URLs,
accession numbers or DOIs. For example,
“All XXX files are available from the XXX
database (accession number(s) XXX,
XXX)." If this information will only be
available after acceptance, please
indicate this by ticking the box below.
If neither of these applies but you are able
to provide details of access elsewhere,
with or without limitations, please do so in
the box below. For example:
“Data are available from the XXX
Institutional Data Access / Ethics
Committee for researchers who meet the
criteria for access to confidential data.”
“Data are from the XXX study whose
authors may be contacted at XXX.”
* typeset
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Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Dr. Mauro Picardo 
The Editor 
PLOS ONE 
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Dear Professor Picardo, 
Thank you for reviewing our manuscript “Identification of cyclobutane pyrimidine dimer-
responsive genes using UVB-irradiated human keratinocytes transfected with in vitro-
synthesized photolyase mRNA” (Manuscript ID PONE-D-15-07621) and for the opportunity 
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the reviewers and performed additional experiments. A separate conclusion section has been 
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We approve Competing Interests statement proposed by editorial manager of PLOS 
ONE. 
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Abstract 21 
Major biological effects of UVB are attributed to cyclobutane pyrimidine dimers (CPDs), the 22 
most common photolesions formed on DNA. To investigate the contribution of CPDs to 23 
UVB-induced changes of gene expression, a model system was established by transfecting 24 
keratinocytes with pseudouridine-modified mRNA (Ψ-mRNA) encoding CPD-photolyase. 25 
Microarray analyses of this model system demonstrated that more than 50% of the gene 26 
expression altered by UVB was mediated by CPD photolesions. Functional classification of 27 
the gene targets revealed strong effects of CPDs on the regulation of the cell cycle and 28 
transcriptional machineries. To confirm the microarray data, cell cycle-regulatory genes, 29 
CCNE1 and CDKN2B that were induced exclusively by CPDs were selected for further 30 
investigation. Following UVB irradiation, expression of these genes increased significantly at 31 
both mRNA and protein levels, but not in cells transfected with CPD-photolyase Ψ-mRNA 32 
and exposed to photoreactivating light. Treatment of cells with inhibitors of c-Jun N-terminal 33 
kinase (JNK) blocked the UVB-dependent upregulation of both genes suggesting a role for 34 
JNK in relaying the signal of UVB-induced CPDs into transcriptional responses. Thus, 35 
photolyase mRNA-based experimental platform demonstrates CPD-dependent and -36 
independent events of UVB-induced cellular responses, and, as such, has the potential to 37 
identify novel molecular targets for treatment of UVB-mediated skin diseases. 38 
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Introduction 39 
The incidence of keratinocyte-derived skin cancer, which is the most common human 40 
malignancy, continues to increase worldwide, thus presenting a serious challenge to 41 
healthcare systems [1]. Ultraviolet B (UVB) (290-320 nm) radiation is the main 42 
environmental risk factor for sunburn, skin carcinogenesis and premature skin ageing [2,3]. 43 
Cyclobutane pyrimidine dimers (CPDs) are the predominant photolesions caused by UVB 44 
radiation, and primarily they are responsible for these adverse effects [4]. CPDs are the most 45 
deleterious and premutagenic photolesions, due to their ability to distort the structure of the 46 
DNA, leading to disturbance of DNA replication and transcription [5,6]. The pathogenetic 47 
role of CPDs is further substantiated by presence of CPD-related signature mutations in genes 48 
involved in the formation of skin cancers [7], as well as, by the correlation between the action 49 
spectrum value for the induction of CPD photolesions and development of UV-induced skin 50 
cancer in animal models [8,9]. In addition, CPDs have been shown to mediate UVB-induced 51 
erythema [10] and immunosuppression [11,12]. Naturally, DNA lesions, including CPDs are 52 
excised by the nucleotide excision repair (NER) system of human keratinocytes [13]. 53 
However, the rate and accuracy of DNA repair by NER are suboptimal [14]. 54 
CPD-photolyase is a structure-specific DNA repair enzyme that specifically binds and 55 
cleaves CPDs using the energy of visible light (“photoreactivation”), thereby simply and 56 
rapidly restoring DNA integrity [15]. This enzyme functions in diverse organisms from 57 
bacteria to vertebrates but is absent in placental mammals, including humans, that must rely 58 
solely on the less potent NER to repair UV-induced DNA lesions [16]. Sunscreen lotions 59 
containing liposomal-encapsulated bacterial photolyase or CPD-specific endonuclease have 60 
been marketed for preventing UV-induced skin damages [17], especially in patients with 61 
NER-deficiency [18]. 62 
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In a previous study, we applied a novel mRNA-based gene delivery method, and 63 
demonstrated that transfection of pseudouridine-modified mRNA (Ψ-mRNA) encoding 64 
Potorous tridactylus CPD-photolyase (CPD-PL) into human keratinocytes leads to rapid 65 
repair of DNA-damage [19]. Pseudouridine modifications increase mRNA stability [20], 66 
make it highly translatable [21,22] and abolish immunogenicity of the RNA [23]. It is well 67 
documented that CPD lesions are considered to be the principal mediator of UV-induced 68 
mutagenesis and DNA double-strand break (DSB) signalling [7,9]. However, so far, it has 69 
been unclear how CPDs change gene expression and cell activities. To gain insight, we 70 
performed a global analysis (microarray) of molecular networks. Most dermatological studies, 71 
in which microarray technology was used, analysed differential expression of genes 72 
comparing normal and pathologic skin samples in order to identify genes associated with a 73 
specific skin condition or with tumor progression [24-28]. Microarray platforms were also 74 
used to identify UV-regulated genes and have uncovered that significant change in the 75 
expression profiles of hundreds of genes are induced by UV. Altered expression of genes in 76 
response to UV irradiation have been determined in epidermal keratinocytes [29], fibroblasts 77 
[30] and melanocytes [31]. Microarray experiments have demonstrated that UVB exposure 78 
affects several biological processes indicating the complexity of UV-induced cellular 79 
activities. Studies performed on human keratinocytes identified UVB-induced genes that were 80 
involved in proteasome-mediated pathways, cytoskeleton organization, cell cycle and 81 
apoptosis networks, and control of basal transcription and translation leading to inhibition of 82 
cell growth [29,32-34]. Furthermore, it has been shown that the repair rate of DNA lesions 83 
alters the UV-induced transcription profile, thus suggesting that adequate removal of the 84 
photoproducts could avoid UV-related cutaneous pathologies [35]. However, until now, there 85 
was no suitable experimental platform to identify directly CPD-responsive genes in human 86 
cells, thus distinguish CPD-regulated cellular mechanisms from those mediated by other 87 
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UVB-induced derivatives, including diverse photoproducts, reactive oxygen species, cross-88 
linked protein-DNA and other damaged macromolecules. 89 
Here, we present data obtained by using human keratinocytes transfected with in vitro-90 
synthesized nucleoside-modified mRNA encoding a marsupial-specific CPD-photolyase. This 91 
model system enabled us to distinguish between CPD-dependent and -independent cellular 92 
processes. We determined the UVB-induced transcriptional responses in human keratinocytes 93 
using the combination of a CPD-specific photolyase Ψ-mRNA delivery with a genomics 94 
approach. Pathway analysis revealed a strong effect of CPDs on the expression levels of 95 
genes involved in the control of the cell cycle and transcriptional machineries. Our findings 96 
demonstrate that the c-Jun N-terminal kinase (JNK) signalling pathway plays a role in 97 
conversion of the cues generated by UVB-induced CPDs into a transcriptional response. 98 
Materials and Methods 99 
RNA synthesis 100 
Messenger RNAs were generated as previously described [19], using linearized plasmids 101 
(pTEV-CPD-PL-A101 and pTEVeGFP-A101) encoding codon-optimized Potorous CPD-102 
photolyase (CPD-PL Ψ-mRNA) and enhanced green fluorescent protein (eGFP Ψ-mRNA). 103 
The CPD-photolyase gene from Potorous tridactylus (rat kangaroo) was synthesized by 104 
Entelechon (Bad Abbach, Germany). The Megascript T7 RNA polymerase kit (Ambion, 105 
Austin, TX) was used for transcription, and UTP was replaced with pseudouridine 106 
triphosphate (TriLink, San Diego, CA) [21]. To remove the template DNA Turbo DNase 107 
(Ambion) was added to the reaction mix. Pseudouridine-modified mRNAs were HPLC-108 
purified as described [36] and provided with cap1 generated by using the m7G capping 109 
enzyme and 2′-O-methyltransferase according to the manufacturer (CellScript, Madison, WI). 110 
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The mRNAs were transcribed to contain 101 nt-long 3’ poly(A) tail. Small aliquots of RNA 111 
samples were stored in siliconized tubes at 20°C. 112 
Keratinocyte cell line 113 
An established HaCaT cell line [37] was maintained in high glucose DMEM (Lonza, 114 
Verviers, Belgium) supplemented with 2 mM L-glutamine (Lonza), 10% fetal bovine serum 115 
(Lonza) and 0.5% antibiotic/antimycotic solution (Sigma-Aldrich, St. Louis, MO, USA) at 116 
37°C with 5% CO2. 117 
Transient transfection and treatments 118 
Transient transfection of Ψ-mRNA into HaCaT cells, UVB exposure and photoreactivation 119 
experiments were carried out, as previously described [19], except that a ratio of mRNA (0.25 120 
µg) and Lipofectamine LTX-PLUS (Life Technologies) reagent (1.0 µl) in a final volume of 121 
100 µl EpiLife keratinocyte growth medium (Life Technologies, Carlsbad, CA, USA) was 122 
used. Following a two-hour transfection, the lipofectamine-RNA complex was replaced with 123 
100 µl fresh culture medium. At 12 h post transfection, the cell monolayer in a well of a 96-124 
well plate, was covered with 50 µl Dulbecco’s phosphate buffer saline (Life Technologies) 125 
and subjected to 20 mJ/cm2 UVB using two TL-20W/12 tubes (Philips). Proper dosage of 126 
UVB was determined by a UVX Digital Radiometer (UVP Inc., San Gabriel, CA, USA). 127 
Immediately after UVB treatment, cells were exposed to visible light (“photoreactivation”) 128 
using F18W Daylight fluorescent tubes (Sylvania) or kept in the dark for one hour. At 5 and 129 
23 h following photoreactivation, total RNA and genomic DNA were isolated from the cells. 130 
Enzyme-linked immunosorbent assay (ELISA) 131 
Genomic DNA was extracted from HaCaT cell line using the Qiagen Blood and Cell Culture 132 
kit (Qiagen, Hilden, Germany), according to the manufacturer. A direct ELISA was applied 133 
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for detection of CPD, as previously described [19]. Anti-CPD monoclonal antibody (TDM-2, 134 
Cosmo Bio, Tokyo, Japan) diluted in PBS (1:1000) was used as primary antibody. 135 
Microarray analysis 136 
Total RNA was isolated from HaCaT cells using Trizol reagent (MRC, Cincinnati, OH, 137 
USA), according to the manufacturer’s instructions. RNA samples were treated by DNase I 138 
(Fermentas, St. Leon-Rot, Germany) and their quality were analyzed using an Agilent 2100 139 
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Gene expression profiling of 140 
HaCaT cells transfected with CPD-photolyase mRNA was performed using a service provider 141 
(ChromoScience, Budapest, Hungary, http://www.chromoscience.hu). Briefly, cyanine 3-142 
labeled cRNA was synthesized from 200 ng total RNA by the QuickAmp Labeling Kit 143 
(Agilent Technologies), according to the manufacturer. For each sample, 1650 ng of one-144 
color labeled cRNA was hybridized to an Agilent 4x44 K Whole Human Genome Oligo 145 
(Agilent Technologies) microarray platform at 65°C for 17 h. All further steps were carried 146 
out according to the manufacturer (Agilent Technologies). The slides were scanned with the 147 
Agilent Microarray Scanner. Data were then normalized by the Feature Extraction software 148 
version 9.5 (Agilent Technologies) with default settings for one-color oligonucleotide 149 
microarrays and then transferred to GeneSpringGX program (Agilent Technologies) for 150 
further statistical evaluation. In GeneSpring, the normalization and data transformation steps 151 
recommended by Agilent Technologies for one-color data were applied at each time point. 152 
Microarray data have been submitted to Gene Expression Omnibus (GEO) [38] database and 153 
can be retrieved at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65034 (GEO 154 
Series accession number: GSE65034). Three replicates of the following 3 types of CPD-PL 155 
-mRNA transfected samples were studied by the microarray: non-irradiated, UVB-irradiated 156 
without photoreactivating light (inactive CPD-photolyase), UVB-irradiated plus 157 
photoreactivated (active CPD-photolyase). Genes showing statistically significant 2-fold 158 
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change were selected for further study by Ingenuity Pathway Analysis (IPA, Qiagen; 159 
http://www.ingenuity.com/products/ipa) and Database for Annotation, Visualization and 160 
Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov) gene functional classification 161 
tool. 162 
Real-time quantitative RT-PCR analysis 163 
To validate the microarray data, real-time quantitative reverse transcription (RT)-PCR was 164 
used. RT was performed using the High-Capacity cDNA Reverse Transcription Kit (Life 165 
Technologies), according to the manufacturer. RT reactions contained 500-500 ng of RNA. 166 
To quantitate the expression of candidate genes, the following TaqMan Gene Expression 167 
assays (Life Technologies) were used: ATF3 (Hs00231069_m1), CCNE1 (Hs01026536_m1), 168 
CDKN2B (p15INK4b) (Hs00793225_m1), EGR1 (Hs00152928_m1), ID2 (Hs04187239_m1), 169 
PTGS2 (COX-2) (Hs00153133_m1), RUNX1 (Hs00231079_m1), SNAI2 (Hs00950344_m1), 170 
the sequences are proprietary and not released by the company. To determine mRNA 171 
expression of SNAI1 the following custom-designed primers and probe set were used: 172 
Forward primer: 5’-ACT ATG CCG CGC TCT TTC-3’; Reverse primer: 5’-GCT GGA AGG 173 
TAA ACT CTG GAT-3’; and the probe sequence is: 5’-[6-carboxyfluorescein (FAM)] AAT 174 
CGG AAG CCT AAC TAC AGC GAG C [tetramethylrhodamine (TAMRA)]-3’. The 175 
composition of RT mixes, the PCR reactions and the RT-PCR protocols were carried out as 176 
previously described [19] using the ABI 7900 HT Sequence Detection System (Life 177 
Technologies). Relative RNA expression values were calculated using the 2-ΔΔCt method [39] 178 
in which expression levels in samples containing active CPD-photolyase were compared to 179 
those containing inactive one. SDHA ((Hs00188166_m1) and PGK1 (Hs00943178_g1) 180 
mRNA levels that showed the smallest variation upon UVB exposure in keratinocytes [40] 181 
were used for normalization. 182 
Western blot analysis 183 
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For Western blot analyses, whole cell extracts were prepared, as previously described [19]. 184 
Proteins (10 g) were separated on 12% polyacrylamide gels and transferred to nitrocellulose 185 
membranes (BioRad, Berkeley, CA, USA). After blocking the membranes in 5% non-fat dry 186 
milk, the membranes were incubated with primary antibodies diluted (1:750) in 5% skimmed 187 
milk at 4C overnight, then with the appropriate secondary antibodies (1:3000) at room 188 
temperature for 1 hour. The following primary antibodies were used: anti-CCNE1 (4129), 189 
anti-ß-actin (3700) (Cell Signaling Technology, Danvers, MA, USA) and anti-CDKN2B 190 
(p15INK4b) (MA1-12294, Thermo Fisher Scientific, Rockford, IL, USA). Goat anti-mouse or 191 
anti-rabbit IgG conjugated with horseradish peroxidase (HRP) was used as a secondary 192 
antibody (BioRad). The visualization of proteins was achieved with ECL Prime Western 193 
blotting detection system (GE Healthcare, Little Chalfont, UK) and densitometry was 194 
performed using ImageJ public software (NIH, Bethesda, MD, USA). 195 
Inhibitor treatment 196 
Keratinocytes at 85% confluency were transfected with lipofectamine-complexed CPD-PL -197 
mRNA. Twelve hours later, cells were pretreated with specific inhibitors of JNK (SP600125), 198 
p38 MAPK (SB203580) or AKT (MK-2206) at a final concentration of 40 µM, 10 µM and 10 199 
µM, respectively for 1 hour before treatment with UVB and subsequent photoreactivation. All 200 
chemical agents were purchased from SelleckChem (Selleck Chemicals, Houston, TX, USA) 201 
and were dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich). Stock solutions were 202 
prepared according to the manufacturer and stored at 20°C. 203 
Statistical evaluation 204 
Identification of genes differentially expressed in microarray experiments was carried out by 205 
the unpaired, Student’s t-test followed by Benjamini-Hochberg correction. Statistical analysis 206 
of qRT-PCR data was performed using GraphPad Prism 5 software (GraphPad Software Inc., 207 
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San Diego, CA, USA). The significance of differences in terms of mRNA expression 208 
comparing UVB-irradiated samples to non-irradiated ones, or UVB-irradiated plus 209 
photoreactivated (active CPD-photolyase) samples to non-photoreactivated (inactive CPD-210 
photolyase) samples, respectively, was determined by the two-tailed, unpaired t-test. A p 211 
value of equal to or less than 0.05 was considered statistically significant. 212 
Results 213 
Accelerated removal of CPD lesions in keratinocytes transfected 214 
with CPD-photolyase mRNA 215 
To test the enzymatic activity of CPD-photolyase translated in HaCaT cells from the 216 
transfected mRNA (CPD-PL Ψ-mRNA), cells were subjected to a physiological dose of UVB 217 
(20 mJ/cm2) 12 h after transfection of lipofectamine-complexed CPD-PL Ψ-mRNA. 218 
Immediately thereafter, cells were either exposed to photoreactivating light, or left in the dark 219 
for 1 hour. Cells were harvested 5 and 23 hours later, and CPD-specific ELISA was 220 
performed to measure the amount of CPDs formed in genomic DNA. The amount of CPDs in 221 
CPD-PL Ψ-mRNA transfected cells was reduced by 90% in those receiving photoreactivating 222 
light (photoreactivated), as compared to cells kept in the dark (non-photoreactivated) (Fig. 1). 223 
Cells transfected with control eGFP Ψ-mRNA contained the highest amount of CPD lesions 224 
at both 6 and 24 h after UVB irradiation (Fig. 1). A reduced amount of CPD lesions were 225 
measured in all irradiated samples at 24 h vs. at 6 h due to slower endogenous NER-mediated 226 
DNA repair. 227 
CPD-dependent changes were distinguished within the UVB-228 
induced alterations of gene expression in human keratinocytes 229 
To determine the CPD-dependent gene expression profile of human keratinocytes exposed to 230 
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UVB irradiation, an oligonucleotide-based DNA microarray analysis was performed in which 231 
HaCaT cells transfected with CPD-PL Ψ-mRNA were used. Total RNA was isolated at 6 and 232 
24 h after UVB exposure and subsequent photoreactivation (or not). Gene expression values 233 
of UVB-irradiated plus photoreactivated samples (active CPD-photolyase) were compared to 234 
non-irradiated samples and to those that were UVB irradiated, but left without 235 
photoreactivation (inactive CPD-photolyase). UVB irradiated, but non-photoreactivated 236 
samples were also compared to non-irradiated samples. Cut-off values for changes in gene 237 
expression were set at  2-fold, and according to this criterion, expression levels of 2,370 out 238 
of 41,000 genes were changed at 6 or 24 h after UVB exposure. Altered expression of 1,334 239 
(56%) of UVB-regulated genes was restored in cells that contained active CPD-photolyase 240 
indicating that the changes in the expression of these genes were CPD-dependent (S1 Fig.). 241 
Importantly, more CPD-dependent gene expression changes (1,008 out of 1,334 genes) were 242 
observed at 6 h vs. 24 h, potentially due to the higher difference in CPD levels at 6 h 243 
comparing cells with active CPD-photolyase to those with inactive one (S1 Fig., S1 and S2 244 
Tables). There are other reasons, such as transient expression of induced genes. On the other 245 
hand, CPD-dependent genes represented more than half of the UVB-regulated genes (1008 246 
out of 1743 genes and 326 out of 627 genes at 6 and 24 h after UVB irradiation, respectively) 247 
at both time points after the exposure (S1 Fig., S1 and S2 Tables). These data suggest that 248 
UVB-induced CPDs mediate a significant portion of the transcriptional alterations after 6 and 249 
24 hours in response to UVB irradiation of human keratinocytes. 250 
UVB-induced, CPD-dependent genes are associated with cellular 251 
stress responses 252 
To determine possible network interactions and associated biological functions of CPD-253 
regulated genes, datasets representing all the differentially expressed genes derived from 254 
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microarray analyses were imported into IPA and DAVID software. Using these applications, 255 
we determined that a majority of CPD-dependent genes at 6 h after UVB exposure belong to 256 
the regulatory network of Cell Cycle and Gene Expression, while those at the 24 h belong to 257 
the network of Cellular Development, Growth and Proliferation (S2A Fig., S3A-S3G Fig.). 258 
The top-rated network of CPD-regulated genes at 6 h after UVB irradiation was centered 259 
around a proto-oncogene (c-Jun); the prostaglandin-endoperoxide synthase 2 (PTGS2), which 260 
is a major mediator of inflammation, and the glucocorticoid receptor (NR3C1), which mainly 261 
functions as a transcription factor (S2B Fig.). In addition, c-Jun and interleukin 6 (IL6), the 262 
transcriptional regulator nuclear factor kappa B (NF-B), p38 and the protein kinase ERK 263 
were central nodes in the top network of CPD-dependent genes at 24 h after UVB exposure 264 
(S2C Fig.). 122 out of the 1008 CPD-regulated genes belonged to the best-scored IPA 265 
network at 6 h after UVB and 60 out of the 326 CPD-regulated genes at 24 h after the 266 
exposure (S2A Fig.). Functional classification of CPD-regulated genes within networks (S2B-267 
S2C Fig.) suggested that a wide range of cell cycle-regulatory genes, positive or negative 268 
regulators of the transcriptional and cell recovery machineries, proto-oncogenes, apoptosis 269 
and protein kinase related genes were uniquely induced or repressed by CPD photolesions 270 
(S3A-S3G Fig.). Nine genes regulated by CPDs were selected for further investigation based 271 
on the microarray data and their involvement in cell cycle regulation (CCNE1, CDKN2B), 272 
transcriptional regulation (ATF3, EGR1, ID2, RUNX1), epithelial to mesenchymal transition 273 
(SNAI1, SNAI2) and inflammation (PTGS2) (Table 1). 274 
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Table 1. Summarized fold change values by microarray results of the selected 9 CPD-dependent genes. 
GenBank ID Gene Description 
6 h after UVB 
irradiation 
24 h after UVB 
irradiation 
vs non-
irradiated 
active PL vs 
inactive PL 
vs non-
irradiated 
active PL vs 
inactive PL 
NM_001040619 ATF3 activating transcription factor 3  5.65 -3.30  1.85 -1.90 
NM_001238 CCNE1 cyclin E1  2.87 -2.14  1.17  1.13 
NM_004936 CDKN2B 
cyclin-dependent kinase inhibitor 
2B 
 7.76 -3.36  2.05 -2.06 
NM_001964 EGR1 early growth response 1  2.51 -3.95  3.38 -2.39 
NM_002166 ID2 inhibitor of DNA binding 2  4.35 -3.89 -2.09  1.45 
NM_000963 PTGS2 
prostaglandin-endoperoxide 
synthase 2 
 6.75 -3.72  4.66 -3.04 
NM_001001890 RUNX1 runt-related transcription factor 1 -4.45  4.36  1.05  1.09 
NM_005985 SNAI1 snail family zinc finger 1   6.44 -3.44  2.76 -2.59 
NM_003068 SNAI2 snail family zinc finger 2  2.39 -2.15  1.59 -1.24 
active PL: samples containing active CPD-photolyase 
inactive PL: samples containing inactive CPD-photolyase 
CPD-dependency of transcriptional changes of 9 genes selected on 275 
the basis of microarray data were confirmed by RT-qPCR 276 
To validate the microarray data, we employed real time quantitative RT-PCR analyses. 277 
Regarding ATF3[41], CCNE1[45], EGR1[41], ID2[42], PTGS2[44], SNAI1[43] and SNAI2[43], UV-278 
induced upregulation of these genes has been previously described [41-45], and our results 279 
were in agreement with the literature. We found significant upregulation of the expression of 280 
CDKN2B (p15INK4b), and downregulation of the expression of RUNX1 in response to UVB 281 
(Fig. 2). Furthermore, presence of active CPD-photolyase significantly prevented the changes 282 
in the expression of all tested genes (Fig. 2), thereby confirming the results of the microarray 283 
analysis. 284 
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Overexpression of cyclin E1 (CCNE1) and p15INK4b (CDKN2B) 285 
proteins in response to UVB is dependent on the generation of 286 
CPD and activation of JNK pathway 287 
For further investigation, we selected two cell cycle-regulatory genes that were less 288 
characterized, related to their involvement in UVB-induced stress response. We have found 289 
that the expression of cyclin E1 and p15INK4b proteins were significantly increased at 24 h 290 
after UVB irradiation, but this increase was prevented by active CPD-photolyase (Fig. 3A-291 
3B). 292 
UVB can activate various protein kinases to regulate cell proliferation and survival pathways 293 
in human keratinocytes [46]. To investigate the signalling pathways involved in modulation 294 
of cyclin E1 and p15INK4b expression upon UVB exposure, HaCaT cells transfected with 295 
CPD-PL -mRNA were first exposed to specific inhibitors of JNK (SP600125), p38 MAPK 296 
(SB203580) or AKT (MK-2206) for 1 h, then immediately subjected to 20 mJ/cm2 of UVB 297 
and subsequent photoreactivating light (active CPD-photolyase) or not (inactive CPD-298 
photolyase). After photoreactivation, cells were cultured in keratinocyte medium containing 299 
inhibitor until harvested at 6 and 24 h. We determined the expression of cyclin E1 and 300 
p15INK4b proteins by western blot analysis. While suppression of p38 MAPK or AKT had 301 
no effect on UVB-induced increase in the levels of these proteins (data not shown), we found 302 
that the treatment of cells with the JNK inhibitor SP600125 abolished the induction of cyclin 303 
E1 and p15INK4b protein expression at 24 h after UVB (Fig. 4). Taken together, these results 304 
indicate that activation of JNK could be responsible for transducing the signal from CPD 305 
lesions towards the induction of CCNE1 and CDKN2B gene expression in UVB-exposed 306 
human keratinocytes. 307 
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Discussion 308 
The use of in vitro-transcribed messenger RNA for delivery of genetic material into 309 
mammalian cells has grown into a novel and alternative tool to oust DNA-based gene transfer 310 
in the last decade [47]. It is well documented that cells transfected with mRNA can synthesize 311 
the encoded protein [47]. We have previously shown that human cultured keratinocytes 312 
expressing CPD-photolyase from transfected in vitro-synthesized mRNA are suitable for 313 
investigating the cellular and molecular effects of UVB-induced CPDs [19]. Optimization of 314 
the transfection procedure resulted in 90% removal of CPDs within the first hour of 315 
photoreactivation, making this platform highly suitable for identification of CPD-dependent 316 
gene expression changes after UVB exposure. UV-induced mutagenesis is attributed to CPDs, 317 
which under normal conditions are repaired by the slow NER system [14]. Mutations in NER 318 
genes result in a less effective and error-prone DNA repair, which increases the probability of 319 
developing cancer [48]. Identification of the genes regulated by CPD photolesions might have 320 
clinical relevance, as it will facilitate defining novel targets for diagnosis or treatment of 321 
UVB-mediated skin diseases. We identified 1334 CPD-responsive genes, which represent 322 
more than 50% of the genes regulated by UVB at 6 and 24 h after the exposure, indicating 323 
that CPDs are major contributors to altered gene expression induced by UVB irradiation, as 324 
well as, to the harmful effects of UVC exposure [49]. These data also indicate that 325 
transcriptional change of a significant number of genes remained the same at 6 or 24 h after 326 
UVB exposure and subsequent photoreactivation in cells transfected with -mRNA encoding 327 
CPD-specific photolyase. This confirms that other UVB-related factors also play a role in 328 
gene regulation, but are independent from CPDs. Such factors include 6-4 photoproduct (6-329 
4PP), which is the second most abundant UV-induced photolesion formed in DNA [50]. 330 
However, the removal of these photoproducts from the mammalian genome is very fast [14], 331 
thus 6-4PPs could potentially contribute to the early wave of UV-induced transcriptional 332 
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response [49]. In addition to 6-4PPs, other UVB-induced products, including reactive oxygen 333 
species, oxidized nucleobases (e.g. 8-oxo-7,8-dihydroxyguanine), crosslinked protein-DNA 334 
are likely to be responsible for CPD-independent transcriptional changes in human 335 
keratinocytes. A significant number of CPD-responsive genes (738 and 250 genes at 6 h and 336 
24 h after the exposure, respectively) were downregulated, most likely due to the stalling of 337 
RNA polymerase II and inhibition of transcription elongation caused by UVB-induced DNA 338 
damage [51]. Furthermore, we found a markedly higher number of CPD-dependent genes to 339 
show altered expression levels at 6 h, as compared to 24 h. 340 
Herein, we mainly focused on analysis of genes regulated by UVB-induced CPD lesions at 341 
6 h after the exposure. Top functional categories were determined among these genes, and we 342 
found that CPD-related gene expression changes were mainly associated with regulation of 343 
the cell cycle and transcriptional machineries in response to UVB irradiation of human 344 
keratinocytes. Molecular studies have provided evidence that recognition of DNA damage, 345 
including UVB-induced photolesions, can temporarily halt cell cycle progression, allowing 346 
time for cells to repair damages prior to replication [52,53]. Unsuccessful repair of these 347 
photoproducts initiates intracellular apoptotic signalling in order to prevent the multiplication 348 
of mutated chromosomes, but may lead to a permanent cell cycle block, genomic instability or 349 
skin carcinogenesis [3,9,12,54]. The importance of cell cycle arrest is supported by studies in 350 
which the function of genes encoding cell cycle inhibitors (INK4 and Cip/Kip family) and cell 351 
cycle regulators (p53, Rb) were analysed [55-58]. A strong correlation has been demonstrated 352 
between the occurrence of CPD-caused “UV fingerprint” mutations in p53 gene and the 353 
development of skin cancer [59]. In addition, p53 was also shown to be regulated by UVB at 354 
a posttranslational rather than at the transcriptional level [60]. And that might be the reason, 355 
why we did not detect a change in the expression of p53 in cells exposed to UVB (GEO 356 
database - GSE65034), but observed CPD-dependent changes in mRNA levels of several p53 357 
17 
 
target genes, including MDM2, ATF3, CCNE1, SNAI1, CDK7, WWOX (Fig. 2, S1 and S2 358 
Tables). These data demonstrated that germline mutations, chemical inactivation or alteration 359 
of cell cycle key regulators, including p53, result in perturbations of cell cycle checkpoint 360 
control leading to the transformation of the cells. Therefore, adequate regulation of cell cycle 361 
arrest is critical to eliminate mutated and potentially malignant cells. According to our 362 
microarray data, CPDs are the primary cause of UVB-induced cell cycle arrest. This finding is 363 
further supported by data demonstrating that photolyase-dependent removal of CPDs prevents 364 
UVB-induced upregulation of negative regulators of cell cycle, including BTG2, CDKN2B 365 
(p15), CDKN1C (p57), GADD45B, and RGS2 (S3A Fig.). Our microarray experiment 366 
provides new data that CPDs are the primary cause of UVB-induced cell cycle arrest [52]. 367 
Among the regulated cell cycle-related genes, CDKN2B, which is involved in G1/S 368 
checkpoint control of cell cycle as well as gain and loss events for p15INK4b have been 369 
extensively studied in recent years [61,62] with less established roles in UVB-mediated 370 
cellular damage in keratinocyte biology. Results of our RT-qPCR and western blotting 371 
analyses showed that the CPD-photolyase mediated repair of UVB-induced CPDs prevented 372 
increased expression of CDKN2B (p15INK4b) mRNA and protein. Loss of p15INK4b 373 
function and CDKN2B mutations has been described in several types of tumors [57,61-63] 374 
confirming that the inactivation of p15INK4b significantly contributes to the transformation 375 
of normal cells into cancer cells. Mutations and deletions in p15INK4b have been 376 
demonstrated in melanoma tumorigenesis [64], and considered to be a heightened risk of 377 
melanoma according to several wide-range examinations [65,66]. Altered expression of 378 
CDKN2B (p15INK4b) mRNA level and new mutations have been detected in patients with 379 
actinic keratosis (AK) suggesting its possible role in AK development [67]. Taken together, 380 
our data strongly suggest the high relevance of CPDs in disruption of cell cycle progression. 381 
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In addition to cell cycle arrest, UVB exposure may affect the cell cycle machinery and cell 382 
proliferation via regulation of target genes involved in apoptosis or inflammation. The most 383 
studied gene associated with UVB-mediated cellular processes is cyclooxygenase 2 (COX-2 384 
or PTGS2). Its upregulation is described as a diagnostic marker and predictive factor in most 385 
tumors and other diseases related to chronic inflammation [68,69]. The role of COX-2 386 
inhibition is paramount important in prevention and treatment of different types of cancer 387 
[70]. In vivo studies have demonstrated that the use of specific inhibitors of COX-2 leads to 388 
accumulation of cells in G0/G1 phase of cell cycle and reduced proliferation of cancer cells 389 
[69]. Our study confirmed upregulation of COX-2 in UVB-irradiated keratinocytes, and here 390 
we also demonstrated that its increased expression was CPD-dependent (Fig. 2, S3E Fig.). 391 
Furthermore, we have identified another gene, CCNE1, which similarly to COX-2 related 392 
to enhanced cell proliferation and upregulated in a CPD-dependent manner. A study using a 393 
mouse model has shown that the cell cycle disturbance in epidermal keratinocytes subjected 394 
to an erythematogenic dose of UVB irradiation is at least in part caused by increased 395 
expression of cyclins, including cyclin E1 [71]. Their data suggests that UVB-induced 396 
hyperplasia and tumorigenesis is partly mediated by the upregulation of cyclin E1 [71], it 397 
however has not been investigated in humans. Several studies suggested that CCNE1 may 398 
represent a useful prognostic marker and has the potential to be a target for therapy in breast 399 
and ovarian cancer [72,73]. This has not yet been investigated in skin cancer. 400 
The second best scored gene network was related to transcriptional machinery. We 401 
validated the microarray results for six transcriptional regulators, ATF3[71], EGR1[72], ID2[73], 402 
RUNX1[74], SNAI1[75] and SNAI2[75]. Mutations or altered expression of these genes has been 403 
reported in various types of cancer, including skin cancer [74-78]. Upregulation of ATF3[41], 404 
EGR1[41], ID2[42], SNAI1[43] and SNAI2[43] has also been implicated in UV-induced cellular 405 
stress responses [41-43]. Here, we have demonstrated that expression of these transcription 406 
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regulators are CPD-dependent, which could serve as novel biomarkers for evaluation of the 407 
involvement of UVB in various photosensitive skin disorders or skin cancers. Our findings 408 
underscore that UVB-induced CPD photolesions play a critical role in tumor development, 409 
including skin carcinogenesis and not only by induction of mutations but also by changing the 410 
expression of physiologically important genes. 411 
The question of how CPD photolesions activate intracellular signalling and how they 412 
modulate the expression of genes in cellular mechanisms (e.g. cell cycle arrest) in response to 413 
UVB irradiation has not been answered. Using CPD-photolyase expressing transgenic mice, it 414 
has been shown previously that unrepaired CPD photolesions are the major mediator of UV-415 
induced transcriptional responses and induce S-phase cell cycle arrest [49]. UV radiation 416 
activates different signal transduction pathways in a wavelength and dose-dependent manner 417 
[79]. It is well established that these signal pathways are regulated by specific protein kinases 418 
including p38 kinase, PKC, AKT and JNK, which play a crucial role in the response network 419 
to skin damage caused by UV exposure [46]. We examined how specific inhibitors of protein 420 
kinases, such as p38 kinase, AKT and JNK, affect gene expression changes initiated by CPD 421 
photolesions. We found that only the JNK inhibitor influenced UVB-induced overexpression 422 
of cyclin E1 and p15INK4b proteins mainly at 24 hours after UVB irradiation. Reviewing the 423 
literature [80] and comparing the data to our microarray findings (S1 and S2 Tables) forty-424 
two CPD-dependent genes could be identified that might be regulated through the activation 425 
of JNK. These findings indicate an important role for JNK kinases in the control of gene 426 
expression modulated by CPD photolesions. These genes are involved in cell adhesion, 427 
apoptosis, regulation of the cell cycle and transcriptional machineries, cytoskeletal 428 
remodelling, cellular development, growth and proliferation. Activation of NF-κB and AP-1 429 
transcription factors (the major downstream targets of the JNK cascade to regulate the 430 
expression of several genes involved in proliferation and survival pathways or inflammation) 431 
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are candidates to mediate the effect of JNK upon UVB irradiation [46]. Increased levels of the 432 
activated form of JNK have been shown in UV exposed keratinocytes [81,82]. It has been 433 
reported that active JNK is mainly associated with keratinocyte proliferation and 434 
differentiation [80,83]. Some studies demonstrated enhanced JNK activity in psoriatic and 435 
wound-healing epidermal cells [84,85], as well as in cylindromas and other hair follicle 436 
derived tumors [86]. Moreover, experiments using animal or human tissue samples suggested 437 
that the JNK-Ap1 signalling pathway has an important role in development of squamous cell 438 
carcinoma and melanoma [86]. It is also possible that CPDs (or other UV-induced DNA-439 
lesions) formed in the promoter or enhancer region of genes alter binding potentials of 440 
transcription factor leading to change in gene expression [87,88]. These published data raise 441 
the question whether expression of certain genes can be changed directly by UV-induced 442 
CPDs formed in their promoter region rather than through a damage-response signalling 443 
pathway. The answer to this question should come from studies with systematic investigation 444 
using specific inhibitors of signalling pathways to prove that indeed the observed 445 
transcriptional changes is mediated through a CPD-dependent signalling event or caused by a 446 
change in the promoter. Studies are ongoing to discern the mechanisms of CPD photolesion-447 
mediated activation of JNK and its downstream effectors. 448 
Conclusion 449 
In vitro-transcribed mRNA can be easily generated and it is a new platform for the delivery of 450 
We demonstrated that in vitro-transcribed mRNA encoding non-human CPD-photolyase can 451 
efficiently be translated into a functional protein in cultured human keratinocytes. Using 452 
pseudouridine-modified mRNA encoding CPD-specific photolyase, which can specifically 453 
remove UVB-induced CPD lesions after exposure to photoreactivating light, we found that 454 
the CPD lesions represents the major contributors to the transcriptional response to UVB 455 
irradiation. Network analysis of CPD-regulated genes revealed that CPDs are principal 456 
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mediators of biological processes related to cell cycle signalling and transcriptional control. 457 
Consequently, the presence of CPDs modulated the transcription profile of many genes that 458 
are involved in the regulation of cell cycle (e.g. CCNE1, CDKN2B) or function as 459 
transcription factors (e.g. ATF3, ID2, RUNX1). Taken together, the results presented here 460 
demonstrates that an approach based on transfection of in vitro-transcribed mRNA is suitable 461 
for distinguishing UVB-induced CPD-dependent and -independent cellular mechanisms, and 462 
explore the molecular details of the involved signalling pathways. 463 
therapeutic proteins opening wide perspectives for dermatological or other medical 464 
utilizations. This novel mRNA-based model provides an opportunity to identify additional 465 
UV-specific molecular targets and achieve a better understanding of UVB-mediated skin 466 
diseases. 467 
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 Figure legends 688 
Figure 1. Accelerated photorepair of CPDs in HaCaT cells transfected with CPD-PL Ψ-689 
mRNA. HaCaT cells were transfected with lipofectamine-complexed Ψ-mRNA encoding 690 
CPD-photolyase. Twelve hours later, cells were subjected to 20 mJ/cm2 UVB and 691 
immediately exposed to photoreactivating light (photoreactivated) or left in the dark (non-692 
photoreactivated) for 1 h and then maintained at 37°C for 5 and 23 hs. After incubation at 5 693 
and 23 h, genomic DNA was isolated at the indicated times after UVB irradiation and the 694 
amount of CPDs was measured by ELISA. The values were calculated relative to those 695 
obtained with cells that were not UVB-irradiated. Significance was assessed by unpaired, 696 
two-sample t-test, p<0.05. Error bars represent the standard error of the mean from three 697 
experiments performed independently. 698 
Figure 2. Experimental verification of microarray results for 9 selected genes. HaCaT 699 
cells were exposed to 20 mJ/cm2 UVB at 12 h after delivery of CPD-PL Ψ-mRNA. 700 
Immediately thereafter, cells were either subjected to photoreactivating light (active CPD-701 
photolyase) or left in the dark (inactive CPD-photolyase) for 1 h. Following incubation total 702 
RNA was extracted at 5 and 23 h, then real-time RT-qPCR was performed to validate the 703 
CPD-dependent expression of ATF3, CCNE1, CDKN2B, EGR1, ID2, PTGS2, RUNX1, 704 
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SNAI1 and SNAI2. Values measured in UVB irradiated cells with or without  705 
photoreactivation were related to those measured in non-UVB irradiated cells that were 706 
transfected control Ψ-mRNA, (pecked lines). Asterisks indicate significant differences (two-707 
tailed, unpaired t-test; p<0.05) between photoreactivated (active CPD-photolyase) and non-708 
photoreactivated (inactive CPD-photolyase) samples. The results of RT-qPCR are means  709 
SEM from three independent experiments in triplicate. 710 
Figure 3. Photorepair of CPDs prevents altered expression of cyclin E1 and p15INK4b 711 
protein in UVB irradiated HaCaT cells. Cells were transfected with lipofectamine-712 
complexed CPD-PL Ψ-mRNA, 12 hs later irradiated with 20 mJ/cm2 UVB and immediately 713 
exposed to photoreactivating light (active CPD-photolyase) or kept in the dark (inactive CPD-714 
photolyase) for 1 h. Subsequently, cells were cultured at 37°C until harvested at the indicated 715 
time after UVB irradiation. (A) The expression of cyclin E1 and p15INK4b were analyzed by 716 
Western blot. (B) Quantitation of western blots displays relative changes in protein expression 717 
normalized to β-actin. Pixel densities were calculated relative to those obtained with cells that 718 
were not UVB irradiated (pecked lines). Significance was assessed by two-tailed, unpaired t-719 
test (asterisk, p<0.05) showing differences between photoreactivated and non-720 
photoreactivated samples. Error bars represent the standard error of the mean. The results are 721 
means of three independent experiments. 722 
Figure 4. Induction of cyclin E1 and p15INK4b protein expression upon UVB exposure 723 
is regulated through the JNK signalling pathway in HaCaT cells. Keratinocytes 724 
transfected with CPD-PL Ψ-mRNA were incubated in serum-free medium supplemented with 725 
JNK inhibitor (SP600125) for 1 h. Immediately thereafter, cells were irradiated with a 726 
physiological dose of UVB or left untreated followed by exposure to photoreactivating light 727 
(or not) for 1 h. The cells were cultured further in serum-free medium supplemented with the 728 
inhibitor. Cells were harvested for western blot assay at the indicated time. Protein levels of 729 
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cyclin E1, p15INK4b, and β-actin are noted. The figure shows representative results from 730 
three independent experiments. 731 
Supporting information 732 
S1 Table. List of all up and downregulated genes related to CPD lesions determined in 733 
CPD-PL -mRNA transfected human keratinocytes at 6 h after UVB exposure by 734 
microarray analyses. 735 
S2 Table. List of all up and downregulated genes related to CPD lesions determined in 736 
CPD-PL -mRNA transfected human keratinocytes at 24 h after UVB exposure by 737 
microarray analyses. 738 
S1 Fig. Divergence of UVB-mediated gene expression changes using CPD-specific 739 
photolyase encoded by in vitro-transcribed mRNA. To characterize the expression profile 740 
of CPD-related genes, oligonucleotide microarray was carried out as described in Materials 741 
and Methods. Bar graph represents the total number of UVB-responsive genes determined 6 742 
and 24 h after the exposure. Bioset was divided into CPD-independent (the presence of active 743 
photolyase had no effect on the expression level of genes modified by UVB irradiation) and 744 
CPD-dependent (the presence of active photolyase has restored the expression level of genes 745 
modified by UVB irradiation) genes. Cut-off values for changes in gene expression were set 746 
at  2-fold. 747 
S2 Fig.  Top network interactions among CPD-dependent genes determined at 6 and 24 748 
h after UVB irradiation in CPD-PL -mRNA transfected keratinocytes. To analyze 749 
network interactions of CPD-dependent genes, datasets representing differentially regulated 750 
genes derived from microarray were imported into the Ingenuity Pathway Analysis (IPA) 751 
application. The list of the top three networks and associated cellular functions of all CPD-752 
related gene datasets are shown with their respective scores and p-values (p < 0.05) obtained 753 
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from IPA (panel A). The score is derived from a p-value and indicates the likelihood of the 754 
focus genes in a network being found together due to random chance (defined as: - log10 (p-755 
value)). The most highly rated networks of genes, determined 6 (panel B) and 24 h (panel C) 756 
after UVB irradiation, are illustrated with the significantly up- (red shaded) and 757 
downregulated (green shaded) genes modulated in a CPD-dependent manner. Genes in empty 758 
nodes were not identified as differentially expressed in our experiment and were generated 759 
automatically by IPA Knowledge Base indicating a relevance to this network. The genes 760 
marked with blue circle have been validated by RT-qPCR. 761 
S3 Fig. Functional classification of CPD-related genes belonging to top rated networks 762 
determined by IPA. To analyze functional classification of CPD-responsive genes belonging 763 
to top networks, datasets derived from the results of network analysis were imported into the 764 
Database for Annotation, Visualization and Integrated Discovery (DAVID) tool. The list of 765 
these CPD-dependent genes, determined at 6 and 24 h after UVB irradiation is shown 766 
according to their cellular functions (panel A-G). Gene expression values measured in 767 
photolyase mRNA transfected and UVB irradiated cells (PL+UVB) were compared to those 768 
measured in non-UVB irradiated control cells, while photolyase mRNA transfected, UVB-769 
irradiated and photoreactivated samples (active CPD-photolyase) were compared to those that 770 
were photolyase mRNA transfected and UVB irradiated, but left without photoreactivation 771 
(inactive CPD-photolyase). Cut-off values for changes in gene expression were set at  2-fold. 772 
To evaluate statistical analysis unpaired, Student’s t-test followed by Benjamini-Hochberg 773 
corrections were used. The genes marked with red boxes were selected for further 774 
investigation. The blue box in (F) represents a gene (IL6) that was confirmed in previous 775 
work [19] to have CPD-dependent changes in expression. 776 
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Abstract 21 
Major biological effects of UVB are attributed to cyclobutane pyrimidine dimers (CPDs), the 22 
most common photolesions formed on DNA. To investigate the contribution of CPDs to 23 
UVB-induced changes of gene expression, a model system was established by transfecting 24 
keratinocytes with pseudouridine-modified mRNA (Ψ-mRNA) encoding CPD-photolyase. 25 
Microarray analyses of this model system demonstrated that more than 50% of the gene 26 
expression altered by UVB was mediated by CPD photolesions. Functional classification of 27 
the gene targets revealed strong effects of CPDs on the regulation of the cell cycle and 28 
transcriptional machineries. To confirm the microarray data, cell cycle-regulatory genes, 29 
CCNE1 and CDKN2B that were induced exclusively by CPDs were selected for further 30 
investigation. Following UVB irradiation, expression of these genes increased significantly at 31 
both mRNA and protein levels, but not in cells transfected with CPD-photolyase Ψ-mRNA 32 
and exposed to photoreactivating light. Treatment of cells with inhibitors of c-Jun N-terminal 33 
kinase (JNK) hinderedblocked the UVB-dependent upregulation of both genes suggesting a 34 
role for JNK in relaying the signal of UVB-induced CPDs into transcriptional responses. 35 
Thus, photolyase mRNA-based experimental platform demonstrates CPD-dependent and -36 
independent events of UVB-induced cellular responses, and, as such, has the potential to 37 
identify novel molecular targets for treatment of UVB-mediated skin diseases. 38 
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Introduction 39 
The incidence of keratinocyte-derived skin cancer, which is the most common human 40 
malignancy, continues to increase worldwide, thus presenting a serious challenge to 41 
healthcare systems [1]. Ultraviolet B (UVB) (290-320 nm) radiation is the main 42 
environmental risk factor for sunburn, skin carcinogenesis and premature skin ageing [2,3]. 43 
Cyclobutane pyrimidine dimers (CPDs) are the predominant photolesions caused by UVB 44 
radiation, and primarily they are responsible for these adverse effects [4]. CPDs are the most 45 
deleterious and premutagenic photolesions, due to their ability to distort the structure of the 46 
DNA, leading to disturbance of DNA replication and transcription [5,6]. The pathogenetic 47 
role of CPDs is further substantiated by presence of CPD-related signature mutations in genes 48 
involved in the formation of skin cancers [7], as well as, by the correlation between the action 49 
spectrum value for the induction of CPD photolesions and development of UV-induced skin 50 
cancer in animal models [8,9]. In addition, CPDs have been shown to mediate UVB-induced 51 
erythema [10] and immunosuppression [11,12]. Naturally, DNA lesions, including CPDs are 52 
excised by the nucleotide excision repair (NER) system of human keratinocytes [13]. 53 
However, the rate and accuracy of DNA repair by NER are suboptimal [14]. 54 
CPD-photolyase is a structure-specific DNA repair enzyme that specifically binds and 55 
cleaves CPDs using the energy of visible light (“photoreactivation”), thereby simply and 56 
rapidly restoring DNA integrity [15]. This enzyme functions in diverse organisms from 57 
bacteria to vertebrates but is absent in placental mammals, including humans, that must rely 58 
solely on the less potent NER to repair UV-induced DNA lesions [16]. Sunscreen lotions 59 
containing liposomal-encapsulated bacterial photolyase or CPD-specific endonuclease have 60 
been marketed for preventing UV-induced skin damages [17], especially in patients with 61 
NER-deficiency [18]. 62 
4 
 
In a previous study, we applied a novel mRNA-based gene delivery method, and 63 
demonstrated that transfection of pseudouridine-modified mRNA (Ψ-mRNA) encoding 64 
Potorous tridactylus CPD-photolyase (CPD-PL) into human keratinocytes leads to rapid 65 
repair of DNA-damage [19]. Pseudouridine modifications increase mRNA stability [20], 66 
make it highly translatable [21,22] and abolish immunogenicity of the RNA [23]. It is well 67 
documented that CPD lesions are considered to be the principal mediator of UV-induced 68 
mutagenesis and DNA double-strand break (DSB) signalling [7,9]. However, so far, it has 69 
been unclear how CPDs change gene expression and cell activities. To gain insight, we 70 
performed a global analysis (microarray) of molecular networks. Most dermatological studies, 71 
in which microarray technology was used, analysed differential expression of genes 72 
comparing normal and pathologic skin samples in order to identify genes associated with a 73 
specific skin condition or with tumor progression [24-28]. Microarray platforms were also 74 
used to identify UV-regulated genes and have uncovered that significant change in the 75 
expression profiles of hundreds of genes are induced by UV. Altered expression of genes in 76 
response to UV irradiation have been determined in epidermal keratinocytes [29], fibroblasts 77 
[30] and melanocytes [31]. Microarray experiments have demonstrated that UVB exposure 78 
affects several biological processes indicating the complexity of UV-induced cellular 79 
activities. Studies performed on human keratinocytes identified UVB-induced genes that were 80 
involved in proteasome-mediated pathways, cytoskeleton organization, cell cycle and 81 
apoptosis networks, and control of basal transcription and translation leading to inhibition of 82 
cell growth [29,32-34]. Furthermore, it has been shown that the repair rate of DNA lesions 83 
alters the UV-induced transcription profile, thus suggesting that adequate removal of the 84 
photoproducts could avoid UV-related cutaneous pathologies [35]. However, until now, there 85 
was no suitable experimental platform to identify directly CPD-responsive genes in human 86 
cells, thus distinguish CPD-regulated cellular mechanisms from those mediated by other 87 
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UVB-induced derivatives, including diverse photoproducts, reactive oxygen species, cross-88 
linked protein-DNA and other damaged macromolecules. 89 
Here, we present data obtained by using human keratinocytes transfected with in vitro-90 
synthesized nucleoside-modified mRNA encoding a marsupial-specific CPD-photolyase. This 91 
model system enabled us to distinguish between CPD-dependent and -independent cellular 92 
processes. We determined the UVB-induced transcriptional responses in human keratinocytes 93 
using the combination of a CPD-specific photolyase Ψ-mRNA delivery with a genomics 94 
approach. Pathway analysis revealed a strong effect of CPDs on the expression levels of 95 
genes involved in the control of the cell cycle and transcriptional machineries. Our findings 96 
demonstrate that the c-Jun N-terminal kinase (JNK) signalling pathway plays a role in 97 
conversion of the cues generated by UVB-induced CPDs into a transcriptional response. 98 
Materials and Methods 99 
RNA synthesis 100 
Messenger RNAs were generated as previously described [19], using linearized plasmids 101 
(pTEV-CPD-PL-A101 and pTEVeGFP-A101) encoding codon-optimized Potorous CPD-102 
photolyase (CPD-PL Ψ-mRNA) and enhanced green fluorescent protein (eGFP Ψ-mRNA). 103 
The CPD-photolyase gene from Potorous tridactylus (rat kangaroo) was synthesized by 104 
Entelechon (Bad Abbach, Germany). The Megascript T7 RNA polymerase kit (Ambion, 105 
Austin, TX) was used for transcription, and UTP was replaced with pseudouridine 106 
triphosphate (TriLink, San Diego, CA) [21]. To remove the template DNA Turbo DNase 107 
(Ambion) was added to the reaction mix. Pseudouridine-modified mRNAs were HPLC-108 
purified as described [36] and provided with cap1 generated by using the m7G capping 109 
enzyme and 2′-O-methyltransferase according to the manufacturer (CellScript, Madison, WI). 110 
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The mRNAs were transcribed to contain 101 nt-long 3’ poly(A) tail. Small aliquots of RNA 111 
samples were stored in siliconized tubes at 20°C. 112 
Keratinocyte cell line 113 
An established HaCaT cell line [37] was maintained in high glucose DMEM (Lonza, 114 
Verviers, Belgium) supplemented with 2 mM L-glutamine (Lonza), 10% fetal bovine serum 115 
(Lonza) and 0.5% antibiotic/antimycotic solution (Sigma-Aldrich, St. Louis, MO, USA) at 116 
37°C with 5% CO2. 117 
Transient transfection and treatments 118 
Transient transfection of Ψ-mRNA into HaCaT cells, UVB exposure and photoreactivation 119 
experiments were carried out, as previously described [19], except that a ratio of mRNA (0.25 120 
µg) and Lipofectamine LTX-PLUS (Life Technologies) reagent (1.0 µl) in a final volume of 121 
100 µl EpiLife keratinocyte growth medium (Life Technologies, Carlsbad, CA, USA) was 122 
used. Following a two-hour transfection, the lipofectamine-RNA complex was replaced with 123 
100 µl fresh culture medium. At 12 h post transfection, the cell monolayer in a well of a 96-124 
well plate, was covered with 50 µl Dulbecco’s phosphate buffer saline (Life Technologies) 125 
and subjected to 20 mJ/cm2 UVB using two TL-20W/12 bulbstubes (Philips). Proper dosage 126 
of UVB was determined by a UVX Digital Radiometer (UVP Inc., San Gabriel, CA, USA). 127 
Immediately after UVB treatment, cells were exposed to visible light (“photoreactivation”) 128 
using F18W Daylight fluorescent bulbstubes (Sylvania) or kept in the dark for one hour. At 5 129 
and 23 h following photoreactivation, total RNA and genomic DNA were isolated from the 130 
cells. 131 
Enzyme-linked immunosorbent assay (ELISA) 132 
Genomic DNA was extracted from HaCaT cell line using the Qiagen Blood and Cell Culture 133 
kit (Qiagen, Hilden, Germany), according to the manufacturer. A direct ELISA was applied 134 
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for detection of CPD, as previously described [19]. Anti-CPD monoclonal antibody (TDM-2, 135 
Cosmo Bio, Tokyo, Japan) diluted in PBS (1:1000) was used as primary antibody. 136 
Microarray analysis 137 
Total RNA was isolated from HaCaT cells using Trizol reagent (MRC, Cincinnati, OH, 138 
USA), according to the manufacturer’s instructions. RNA samples were treated by DNase I 139 
(Fermentas, St. Leon-Rot, Germany) and their quality were analyzed using an Agilent 2100 140 
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Gene expression profiling of 141 
HaCaT cells transfected with CPD-photolyase mRNA was performed using a service provider 142 
(ChromoScience, Budapest, Hungary, http://www.chromoscience.hu). Briefly, cyanine 3-143 
labeled cRNA was synthesized from 200 ng total RNA by the QuickAmp Labeling Kit 144 
(Agilent Technologies), according to the manufacturer. For each sample, 1650 ng of one-145 
color labeled cRNA was hybridized to an Agilent 4x44 K Whole Human Genome Oligo 146 
(Agilent Technologies) microarray platform at 65°C for 17 h. All further steps were carried 147 
out according to the manufacturer (Agilent Technologies). The slides were scanned with the 148 
Agilent Microarray Scanner. Data were then normalized by the Feature Extraction software 149 
version 9.5 (Agilent Technologies) with default settings for one-color oligonucleotide 150 
microarrays and then transferred to GeneSpringGX program (Agilent Technologies) for 151 
further statistical evaluation. In GeneSpring, the normalization and data transformation steps 152 
recommended by Agilent Technologies for one-color data were applied at each time point. 153 
Microarray data have been submitted to Gene Expression Omnibus (GEO) [38] database and 154 
can be retrieved at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65034 (GEO 155 
Series accession number: GSE65034). Three replicates of the following 3 types of CPD-PL 156 
-mRNA transfected samples were studied by the microarray: non-irradiated, UVB-irradiated 157 
without photoreactivating light (inactive CPD-photolyase), UVB-irradiated plus 158 
photoreactivated (active CPD-photolyase). Genes showing statistically significant 2-fold 159 
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change were selected for further study by Ingenuity Pathway Analysis (IPA, Qiagen; 160 
http://www.ingenuity.com/products/ipa) and Database for Annotation, Visualization and 161 
Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov) gene functional classification 162 
tool. 163 
Real-time quantitative RT-PCR analysis 164 
To validate the microarray data, real-time quantitative reverse transcription (RT)-PCR was 165 
used. RT was performed using the High-Capacity cDNA Reverse Transcription Kit (Life 166 
Technologies), according to the manufacturer. RT reactions contained 500-500 ng of RNA. 167 
To quantitate the expression of candidate genes, the following TaqMan Gene Expression 168 
assays (Life Technologies) were used: ATF3 (Hs00231069_m1), CCNE1 (Hs01026536_m1), 169 
CDKN2B (p15INK4b) (Hs00793225_m1), EGR1 (Hs00152928_m1), ID2 (Hs04187239_m1), 170 
PTGS2 (COX-2) (Hs00153133_m1), RUNX1 (Hs00231079_m1), SNAI2 (Hs00950344_m1), 171 
the sequences are proprietary and not released by the company. To determine mRNA 172 
expression of SNAI1 the following custom-designed primers and probe set were used: 173 
Forward primer: 5’-ACT ATG CCG CGC TCT TTC-3’; Reverse primer: 5’-GCT GGA AGG 174 
TAA ACT CTG GAT-3’; and the probe sequence is: 5’-[6-carboxyfluorescein (FAM)] AAT 175 
CGG AAG CCT AAC TAC AGC GAG C [tetramethylrhodamine (TAMRA)]-3’. The 176 
composition of RT mixes, the PCR reactions and the RT-PCR protocols were carried out as 177 
previously described [19] using the ABI 7900 HT Sequence Detection System (Life 178 
Technologies). Relative RNA expression values were calculated using the 2-ΔΔCt method [39] 179 
in which expression levels in samples containing active CPD-photolyase were compared to 180 
those containing inactive one. SDHA ((Hs00188166_m1) and PGK1 (Hs00943178_g1) 181 
mRNA levels that showed the smallest variation upon UVB exposure in keratinocytes [40] 182 
were used for normalization. 183 
Western blot analysis 184 
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For Western blot analyses, whole cell extracts were prepared, as previously described [19]. 185 
Proteins (10 g) were separated on 12% polyacrylamide gels and transferred to nitrocellulose 186 
membranes (BioRad, Berkeley, CA, USA). After blocking the membranes in 5% non-fat dry 187 
milk, the membranes were incubated with primary antibodies diluted (1:750) in 5% skimmed 188 
milk at 4C overnight, then with the appropriate secondary antibodies (1:3000) at room 189 
temperature for 1 hour. The following primary antibodies were used: anti-CCNE1 (4129), 190 
anti-ß-actin (3700) (Cell Signaling Technology, Danvers, MA, USA) and anti-CDKN2B 191 
(p15INK4b) (MA1-12294, Thermo Fisher Scientific, Rockford, IL, USA). Goat anti-mouse or 192 
anti-rabbit IgG conjugated with horseradish peroxidase (HRP) was used as a secondary 193 
antibody (BioRad). The visualization of proteins was achieved with ECL Prime Western 194 
blotting detection system (GE Healthcare, Little Chalfont, UK) and densitometry was 195 
performed using ImageJ public software (NIH, Bethesda, MD, USA). 196 
Inhibitor treatment 197 
Keratinocytes at 85% confluency were transfected with lipofectamine-complexed CPD-PL -198 
mRNA. cultured until reaching approximately 85-95% confluency andTwelve hours later, 199 
cells were pretreated with specific inhibitors of JNK (SP600125), p38 MAPK (SB203580) or 200 
AKT (MK-2206 2HCl) for 1 hour before UVB irradiation at a final concentration of 40 µM, 201 
10 µM and 10 µM, respectively for 1 hour before treatment with UVB and subsequent 202 
photoreactivation. All chemical agents were purchased from SelleckChem (Selleck 203 
Chemicals, Houston, TX, USA) and were dissolved in dimethyl sulfoxide (DMSO) (Sigma-204 
Aldrich). Stock solutions were prepared according to the manufacturer and stored at 20°C. 205 
Statistical evaluation 206 
Identification of genes differentially expressed in microarray experiments was carried out by 207 
the unpaired, Student’s t-test followed by Benjamini-Hochberg correction. Statistical analysis 208 
10 
 
of qRT-PCR data was performed using GraphPad Prism 5 software (GraphPad Software Inc., 209 
San Diego, CA, USA). The significance of differences in terms of mRNA expression 210 
comparing UVB-irradiated samples to non-irradiated ones, or UVB-irradiated plus 211 
photoreactivated (active CPD-photolyase) samples to non-photoreactivated (inactive CPD-212 
photolyase) samples, respectively, was determined by the two-tailed, unpaired t-test. A p 213 
value of equal to or less than 0.05 was considered statistically significant. 214 
Results 215 
Accelerated removal of CPD lesions in keratinocytes transfected 216 
with CPD-photolyase mRNA 217 
To test the enzymatic activity of CPD-photolyase translated in HaCaT cells from the 218 
transfected mRNA (CPD-PL Ψ-mRNA), cells were subjected to a physiological dose of UVB 219 
(20 mJ/cm2) 12 h after transfection of lipofectamine-complexed CPD-PL Ψ-mRNA. 220 
Immediately thereafter, cells were either exposed to photoreactivating light, or left in the dark 221 
for 1 hour. Cells were harvested at 5 and 23 hours later, and CPD-specific ELISA was 222 
performed to measure the amount of CPDs formed in genomic DNA. The amount of CPDs in 223 
CPD-PL Ψ-mRNA transfected cells was reduced by 90% in those receiving photoreactivating 224 
light (photoreactivated), as compared to cells kept in the dark (non-photoreactivated) (Fig. 1). 225 
Cells transfected with control eGFP Ψ-mRNA contained the highest amount of CPD lesions 226 
at both 6 and 24 h after UVB irradiation (Fig. 1). A reduced amount of CPD lesions were 227 
measured in all irradiated samples at 24 h vs. at 6 h due to slower endogenous NER-mediated 228 
DNA repair. 229 
Figure 1. Accelerated photorepair of CPDs in HaCaT cells transfected with CPD-PL Ψ-230 
mRNA. HaCaT cells were transfected with lipofectamine-complexed Ψ-mRNA encoding 231 
CPD-photolyase. Twelve hours later, cells were subjected to 20 mJ/cm2 UVB and 232 
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immediately exposed to photoreactivating light (photoreactivated) or left in the dark (non-233 
photoreactivated) for 1 h and then maintained at 37°C for 5 and 23 h. After incubation 5 and 234 
23 h, genomic DNA was isolated at the indicated times after UVB irradiation and the amount 235 
of CPDs was measured by ELISA. The values were calculated relative to those obtained with 236 
cells that were not UVB-irradiated. Significance was assessed by unpaired, two-sample t-test, 237 
p<0.05. Error bars represent the standard error of the mean from three experiments performed 238 
independently. 239 
CPD-dependent changes were distinguished within the UVB-240 
induced alterations of gene expression in human keratinocytes 241 
To determine the CPD-dependent gene expression profile of human keratinocytes exposed to 242 
UVB irradiation, an oligonucleotide-based DNA microarray analysis was performed in which 243 
HaCaT cells transfected with CPD-PL Ψ-mRNA were used. Total RNA was isolated at 6 and 244 
24 h after UVB exposure and subsequent photoreactivation (or not). Gene expression values 245 
of UVB-irradiated plus photoreactivated samples (active CPD-photolyase) were compared to 246 
non-irradiated samples and to those that were UVB irradiated, but left without 247 
photoreactivation (inactive CPD-photolyase). UVB irradiated, but non-photoreactivated 248 
samples were also compared to non-irradiated samples. Cut-off values for changes in gene 249 
expression were set at  2-fold, and according to this criterion, expression levels of 2,370 out 250 
of 41,000 genes were changed at 6 or 24 h after UVB exposure. Altered expression of 1,334 251 
(56%) of UVB-regulated genes was restored in cells that contained active CPD-photolyase 252 
indicating that the changes in the expression of these genes were CPD-dependent (S1 Fig.). 253 
Importantly, more CPD-dependent gene expression changes (1,008 out of 1,334 genes) were 254 
observed at 6 h vs. 24 h, potentially due to the higher difference in CPD levels at 6 h 255 
comparing cells with active CPD-photolyase to those with inactive one (S1 Fig., S1 and S2 256 
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Tables). There are other reasons, such as transient expression of induced genes. On the other 257 
hand, CPD-dependent genes represented more than half of the UVB-regulated genes (1008 258 
out of 1743 genes and 326 out of 627 genes at 6 and 24 h after UVB irradiation, respectively) 259 
at both time points after the exposure (S1 Fig., S1 and S2 Tables). These data suggest that 260 
UVB-induced CPDs mediate a significant portion of the transcriptional alterations after 6 and 261 
24 hours in response to UVB irradiation of human keratinocytes. 262 
UVB-induced, CPD-dependent genes are associated with cellular 263 
stress responses 264 
To determine possible network interactions and associated biological functions of CPD-265 
regulated genes, datasets representing all the differentially expressed genes derived from 266 
microarray analyses were imported into IPA and DAVID software. Using these applications, 267 
we determined that a majority of CPD-dependent genes at 6 h after UVB exposure belong to 268 
the regulatory network of Cell Cycle and Gene Expression, while those at the 24 h belong to 269 
the network of Cellular Development, Growth and Proliferation (S2A Fig., S3A-S3G Fig.). 270 
The top-rated network of CPD-regulated genes at 6 h after UVB irradiation was centered 271 
around a proto-oncogene (c-Jun); the prostaglandin-endoperoxide synthase 2 (PTGS2), which 272 
is a major mediator of inflammation, and the glucocorticoid receptor (NR3C1), which mainly 273 
functions as a transcription factor (S2B Fig.). In addition, c-Jun and interleukin 6 (IL6), the 274 
transcriptional regulator nuclear factor kappa B (NF-B), p38 and the protein kinase ERK 275 
were central nodes in the top network of CPD-dependent genes at 24 h after UVB exposure 276 
(S2C Fig.). 122 out of the 9661008 CPD-regulated genes belonged to the best-scored IPA 277 
network at 6 h after UVB and 60 out of the 175326 CPD-regulated genes at 24 h after the 278 
exposure (S2A Fig.). Functional classification of CPD-regulated genes within networks (S2B-279 
S2C Fig.) suggested that a wide range of cell cycle-regulatory genes, positive or negative 280 
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regulators of the transcriptional and cell recovery machineries, proto-oncogenes, apoptosis 281 
and protein kinase related genes were uniquely induced or repressed by CPD photolesions 282 
(S3A-S3G Fig.). Nine genes regulated by CPDs were selected for further investigation based 283 
on the microarray data and their involvement in cell cycle regulation (CCNE1, CDKN2B), 284 
transcriptional regulation (ATF3, EGR1, ID2, RUNX1), epithelial to mesenchymal transition 285 
(SNAI1, SNAI2) and inflammation (PTGS2) (Table 1). 286 
Table 1. Summarized fold change values by microarray results of the selected 9 CPD-dependent genes. 
GenBank ID Gene Description 
6 h after UVB 
irradiation 
24 h after UVB 
irradiation 
vs non-
irradiated 
active PL vs 
inactive PL 
vs non-
irradiated 
active PL vs 
inactive PL 
NM_001040619 ATF3 activating transcription factor 3  5.65 -3.30  1.85 -1.90 
NM_001238 CCNE1 cyclin E1  2.87 -2.14  1.17  1.13 
NM_004936 CDKN2B 
cyclin-dependent kinase inhibitor 
2B 
 7.76 -3.36  2.05 -2.06 
NM_001964 EGR1 early growth response 1  2.51 -3.95  3.38 -2.39 
NM_002166 ID2 inhibitor of DNA binding 2  4.35 -3.89 -2.09  1.45 
NM_000963 PTGS2 
prostaglandin-endoperoxide 
synthase 2 
 6.75 -3.72  4.66 -3.04 
NM_001001890 RUNX1 runt-related transcription factor 1 -4.45  4.36  1.05  1.09 
NM_005985 SNAI1 snail family zinc finger 1   6.44 -3.44  2.76 -2.59 
NM_003068 SNAI2 snail family zinc finger 2  2.39 -2.15  1.59 -1.24 
active PL: samples containing active CPD-photolyase 
inactive PL: samples containing inactive CPD-photolyase 
CPD-dependency of transcriptional changes of 9 genes selected on 287 
the basis of microarray data were confirmed by RT-qPCR 288 
To validate the microarray data, we employed real time quantitative RT-PCR analyses. 289 
Regarding ATF3[41], CCNE1[45], EGR1[41], ID2[42], PTGS2[44], SNAI1[43] and SNAI2[43], UV-290 
induced upregulation of these genes has been previously described [41-45], and our results 291 
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were in agreement with the literature. We found significant upregulation of the expression of 292 
CDKN2B (p15INK4b), and downregulation of the expression of RUNX1 in response to UVB 293 
(Fig. 2). Furthermore, presence of active CPD-photolyase significantly prevented the changes 294 
in the expression of all tested genes (Fig. 2), thereby confirming the results of the microarray 295 
analysis. 296 
Figure 2. Experimental verification of microarray results for 9 selected genes. HaCaT 297 
cells were exposed to 20 mJ/cm2 UVB 12 h after delivery of CPD-PL Ψ-mRNA. Immediately 298 
thereafter, cells were either subjected to photoreactivating light (active CPD-photolyase) or 299 
left in the dark (inactive CPD-photolyase) for 1 h. Following incubation total RNA was 300 
extracted at 5 and 23 h, then real-time RT-qPCR was performed to validate the CPD-301 
dependent expression of ATF3, CCNE1, CDKN2B, EGR1, ID2, PTGS2, RUNX1, SNAI1 302 
and SNAI2. Values measured in UVB irradiated cells with or without  photoreactivation were 303 
related to those measured in non-UVB irradiated cells that were transfected control Ψ-mRNA, 304 
(pecked lines). Asterisks indicate significant differences (two-tailed, unpaired t-test; p<0.05) 305 
between photoreactivated (active CPD-photolyase) and non-photoreactivated (inactive CPD-306 
photolyase) samples. The results of RT-qPCR are means  SEM from three independent 307 
experiments in triplicate. 308 
Overexpression of cyclin E1 (CCNE1) and p15INK4b (CDKN2B) 309 
proteins in response to UVB is dependent on the generation of 310 
CPD and activation of JNK pathway 311 
For further investigation, we selected two cell cycle-regulatory genes that were less 312 
characterized, related to their involvement in UVB-induced stress response. We have found 313 
that the expression of cyclin E1 and p15INK4b proteins were significantly increased at 24 h 314 
after UVB irradiation, but this increase was prevented by active CPD-photolyase (Fig. 3A-315 
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3B). 316 
Figure 3. Photorepair of CPDs prevents altered expression of cyclin E1 and p15INK4b 317 
protein in UVB irradiated HaCaT cells. Cells were transfected with lipofectamine-318 
complexed CPD-PL Ψ-mRNA, 12 h later irradiated with 20 mJ/cm2 UVB and immediately 319 
exposed to photoreactivating light (active CPD-photolyase) or kept in the dark (inactive CPD-320 
photolyase) for 1 h. Subsequently, cells were cultured at 37°C until harvested at the indicated 321 
time after UVB irradiation. (A) The expression of cyclin E1 and p15INK4b were analyzed by 322 
Western blot. (B) Quantitation of western blots displays relative changes in protein expression 323 
normalized to β-actin. Pixel densities were calculated relative to those obtained with cells that 324 
were not UVB irradiated (pecked lines). Significance was assessed by two-tailed, unpaired t-325 
test (asterisk, p<0.05) showing differences between photoreactivated and non-326 
photoreactivated samples. Error bars represent the standard error of the mean. The results are 327 
means of three independent experiments. 328 
UVB can activate various protein kinases to regulate cell proliferation and survival pathways 329 
in human keratinocytes [46]. To investigate the signalling pathways involved in modulation 330 
of cyclin E1 and p15INK4b expression upon UVB exposure, HaCaT cells transfected with 331 
CPD-PL -mRNA were first exposed to specific inhibitors of JNK (SP600125), p38 MAPK 332 
(SB203580) or AKT (MK-2206 2HCl) for 1 h, then immediately subjected to 20 mJ/cm2 of 333 
UVB and subsequent photoreactivating light (active CPD-photolyase) or not (inactive CPD-334 
photolyase). After photoreactivation, Subsequently, cells were cultured in keratinocyte 335 
medium containing inhibitor until harvested at 6 and 24 h. We determined the expression of 336 
cyclin E1 and p15INK4b proteins by western blot analysis. While suppression of p38 MAPK 337 
or AKT had no effect on UVB-induced increase in the levels of these proteins (data not 338 
shown), we found that the treatment of cells with the JNK inhibitor SP600125 abolished the 339 
induction of cyclin E1 and p15INK4b protein expression at 24 h after UVB (Fig. 4). Taken 340 
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together, these results indicate that activation of JNK could be responsible for transducing the 341 
signal from CPD lesions towards the induction of CCNE1 and CDKN2B gene expression in 342 
UVB-exposed human keratinocytes. 343 
Figure 4. Induction of cyclin E1 and p15INK4b protein expression upon UVB exposure 344 
is regulated through the JNK signalling pathway in HaCaT cells. Keratinocytes were 345 
incubated in serum-free medium supplemented with JNK inhibitor (SP600125) for 1 h, then 346 
irradiated with a physiological dose of UVB or left untreated. The cells were cultured further 347 
in serum-free medium supplemented with the inhibitor. Cells were harvested for western blot 348 
assay at the indicated time. Protein levels of cyclin E1, p15INK4b, and β-actin are noted. The 349 
figure shows representative results from three independent experiments. 350 
Discussion 351 
The use of in vitro-transcribed messenger RNA for delivery of genetic material into 352 
mammalian cells has grown into a novel and alternative tool to oust DNA-based gene transfer 353 
in the last decade [47]. It is well documented that cells transfected with mRNA can synthesize 354 
the encoded protein [47]. We have previously shown that human cultured keratinocytes 355 
expressing CPD-photolyase from transfected in vitro-synthesized mRNA are suitable for 356 
investigating the cellular and molecular effects of UVB-induced CPDs [19]. Optimization of 357 
the transfection procedure resulted in 90% removal of CPDs within the first hour of 358 
photoreactivation, making this platform highly suitable for identification of CPD-dependent 359 
gene expression changes after UVB exposure. UV-induced mutagenesis is attributed to CPDs, 360 
which under normal conditions are repaired by the slow NER system [14]. Mutations in NER 361 
genes result in a less effective and error-prone DNA repair, which increases the probability of 362 
developing cancer [48]. Identification of the genes regulated by CPD photolesions might have 363 
clinical relevance, as it will facilitate defining novel targets for diagnosis or treatment of 364 
UVB-mediated skin diseases. We identified 1334 CPD-responsive genes, which represent 365 
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more than 50% of the genes regulated by UVB at 6 and 24 h after the exposure, indicating 366 
that CPDs are major contributors to altered gene expression induced by UVB irradiation, as 367 
well as, to the harmful effects of UVC exposure [49]. These data also indicate that 368 
transcriptional change of a significant number of genes remained the same at 6 or 24 h after 369 
UVB exposure and subsequent photoreactivation in cells transfected with -mRNA encoding 370 
CPD-specific photolyase. This confirms that other UVB-related factors also play a role in 371 
gene regulation, but are independent from CPDs. Such factors include 6-4 photoproduct (6-372 
4PP), which is the second most abundant UV-induced photolesion formed in DNA [50]. 373 
However, the removal of these photoproducts from the mammalian genome is very fast [14], 374 
thus 6-4PPs could potentially contribute to the early wave of UV-induced transcriptional 375 
response [49]. In addition to 6-4PPs, other UVB-induced products, including reactive oxygen 376 
species, oxidized nucleobases (e.g. 8-oxo-7,8-dihydroxyguanine), crosslinked protein-DNA 377 
are likely to be responsible for CPD-independent transcriptional changes in human 378 
keratinocytes. A significant number of theseCPD-responsive genes (738 and 250 genes at 6 h 379 
and 24 h after the exposure, respectively) were downregulated, most likely due to the stalling 380 
of RNA polymerase II and inhibition of transcription elongation caused by UVB-induced 381 
DNA damage [51]. Furthermore, we found a markedly higher number of CPD-dependent 382 
genes to show altered expression levels at 6 h, as compared to 24 h. 383 
Herein, we mainly focused on analysis of genes regulated by UVB-induced CPD lesions at 384 
6 h after the exposure. Top functional categories were determined among these genes, and we 385 
found that CPD-related gene expression changes were mainly associated with regulation of 386 
the cell cycle and transcriptional machineries in response to UVB irradiation of human 387 
keratinocytes. Molecular studies have provided evidence that recognition of DNA damage, 388 
including UVB-induced photolesions, can temporarily halt cell cycle progression, allowing 389 
time for cells to repair damages prior to replication [52,53]. Unsuccessful repair of these 390 
18 
 
photoproducts initiates intracellular apoptotic signalling in order to prevent the multiplication 391 
of mutated chromosomes, but may lead to a permanent cell cycle block, genomic instability or 392 
skin carcinogenesis [3,9,12,54]. The importance of cell cycle arrest is supported by studies in 393 
which the function of genes encoding cell cycle inhibitors (INK4 and Cip/Kip family) and cell 394 
cycle regulators (p53, Rb) were analysed [55-58]. A strong correlation has been demonstrated 395 
between the occurrence of CPD-caused “UV fingerprint” mutations in p53 gene and the 396 
development of skin cancer [59]. In addition, p53 was also shown to be regulated by UVB at 397 
a posttranslational rather than at the transcriptional level [60]. And that might be the reason, 398 
why we did not detect a change in the expression of p53 in cells exposed to UVB (GEO 399 
database - GSE65034), but observed CPD-dependent changes in mRNA levels of several p53 400 
target genes, including MDM2, ATF3, CCNE1, SNAI1, CDK7, WWOX (Fig. 2, S1 and S2 401 
Tables). These data demonstrated that germline mutations or, chemical inactivation or 402 
alteration of these cell cycle key regulators, including p53, could result in perturbations of cell 403 
cycle checkpoint control leading to the transformation of the cells. Therefore, adequate 404 
regulation of cell cycle arrest is critical to eliminate mutated and potentially malignant cells. 405 
According to our microarray data, CPDs are the primary cause of UVB-induced cell cycle 406 
arrest. This finding is further supported by data demonstrating that photolyase-dependent 407 
removal of CPDs prevents UVB-induced upregulation of negative regulators of cell cycle, 408 
including BTG2, CDKN2B (p15), CDKN1C (p57), GADD45B, and RGS2 (S3A Fig.). Our 409 
microarray experiment provides new data that CPDs are the primary cause of UVB-induced 410 
cell cycle arrest [52]. 411 
Among the regulated cell cycle-related genes, CDKN2B, which is involved in G1/S 412 
checkpoint control of cell cycle as well as gain and loss events for p15INK4b have been 413 
extensively studied in recent years [61,62] with less established roles in UVB-mediated 414 
cellular damage in keratinocyte biology. Results of our RT-qPCR and western blotting 415 
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analyses showed that the CPD-photolyase mediated repair of UVB-induced CPDs prevented 416 
increased expression of CDKN2B (p15INK4b) mRNA and protein. Loss of p15INK4b 417 
function and CDKN2B mutations has been described in several types of tumors [57,61-63] 418 
confirming that the inactivation of p15INK4b significantly contributes to the transformation 419 
of normal cells into cancer cells. Mutations and deletions in p15INK4b have been 420 
demonstrated in melanoma tumorigenesis [64], and considered to be a heightened risk of 421 
melanoma according to several wide-range examinations [65,66]. Altered expression of 422 
CDKN2B (p15INK4b) mRNA level and new mutations have been detected in patients with 423 
actinic keratosis (AK) suggesting its possible role in AK development [67]. Taken together, 424 
our data strongly suggest the high relevance of CPDs in disruption of cell cycle progression. 425 
In addition to cell cycle arrest, UVB exposure may affect the cell cycle machinery and cell 426 
proliferation via regulation of target genes involved in apoptosis or inflammation. The most 427 
studied gene associated with UVB-mediated cellular processes is cyclooxygenase 2 (COX-2 428 
or PTGS2). Its upregulation is described as a diagnostic marker and predictive factor in most 429 
tumors and other diseases related to chronic inflammation [68,69]. The role of COX-2 430 
inhibition is paramount important in prevention and treatment of different types of cancer 431 
[70]. In vivo studies have demonstrated that the use of specific inhibitors of COX-2 leads to 432 
accumulation of cells in G0/G1 phase of cell cycle and reduced proliferation of cancer cells 433 
[69]. Our study confirmed upregulation of COX-2 in UVB-irradiated keratinocytes, and here 434 
we also demonstrated that its increased expression was CPD-dependent (Fig. 2, S3E Fig.). 435 
Furthermore, we have identified another gene, CCNE1, which similarly to COX-2 related 436 
to enhanced cell proliferation and upregulated in a CPD-dependent manner. A study using a 437 
mouse model has shown that the cell cycle disturbance in epidermal keratinocytes subjected 438 
to an erythematogenic dose of UVB irradiation is at least in part caused by increased 439 
expression of cyclins, including cyclin E1 [71]. Their data suggests that UVB-induced 440 
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hyperplasia and tumorigenesis is partly mediated by the upregulation of cyclin E1 [71], it 441 
however has not been investigated in humans. Several studies suggested that CCNE1 may 442 
represent a useful prognostic marker and has the potential to be a target for therapy in breast 443 
and ovarian cancer [72,73]. This has not yet been investigated in skin cancer. 444 
The second best scored gene network was related to transcriptional machinery. We 445 
validated the microarray results for six transcriptional regulators, ATF3[71], EGR1[72], ID2[73], 446 
RUNX1[74], SNAI1[75] and SNAI2[75]. Mutations or altered expression of these genes has been 447 
reported in various types of cancer, including skin cancer [74-78]. Upregulation of ATF3[41], 448 
EGR1[41], ID2[42], SNAI1[43] and SNAI2[43] has also been implicated in UV-induced cellular 449 
stress responses [41-43]. Here, we have demonstrated that expression of these transcription 450 
regulators are CPD-dependent, which could serve as novel biomarkers for evaluation of the 451 
involvement of UVB in various photosensitive skin disorders or skin cancers. Our findings 452 
underscore that UVB-induced CPD photolesions play a critical role in tumor development, 453 
including skin carcinogenesis and not only by induction of mutations but also by changing the 454 
expression of physiologically important genes. 455 
The question of how CPD photolesions activate intracellular signalling and how they 456 
modulate the expression of genes in cellular mechanisms (e.g. cell cycle arrest) in response to 457 
UVB irradiation has not been answered. Using CPD-photolyase expressing transgenic mice, it 458 
has been shown previously that unrepaired CPD photolesions are the major mediator of UV-459 
induced transcriptional responses and induce S-phase cell cycle arrest [49]. UV radiation 460 
activates different signal transduction pathways in a wavelength and dose-dependent manner 461 
[79]. It is well established that these signal pathways are regulated by specific protein kinases 462 
including p38 kinase, PKC, AKT and JNK, which play a crucial role in the response network 463 
to skin damage caused by UV exposure [46]. We examined how specific inhibitors of protein 464 
kinases, such as p38 kinase, AKT and JNK, affect gene expression changes initiated by CPD 465 
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photolesions. We found that only the JNK inhibitor influenced UVB-induced overexpression 466 
of Ccyclin E1 and p15INK4b proteins mainly at 24 hours after UVB irradiation. Reviewing 467 
the literature [80] and comparing the data to our microarray findings (S1 and S2 Tables) 468 
forty-two CPD-dependent genes could be identified that might be regulated through the 469 
activation of JNK. These findings indicate an important role for JNK kinases in the control of 470 
gene expression modulated by CPD photolesions. These genes are involved in cell adhesion, 471 
apoptosis, regulation of the cell cycle and transcriptional machineries, cytoskeletal 472 
remodelling, cellular development, growth and proliferation. Activation of NF-κB and AP-1 473 
transcription factors (the major downstream targets of the JNK cascade to regulate the 474 
expression of several genes involved in proliferation and survival pathways or inflammation) 475 
are candidates to mediate the effect of JNK upon UVB irradiation [46]. Increased levels of the 476 
activated form of JNK have been shown in UV exposed keratinocytes [81,82]. It has been 477 
reported that active JNK is mainly associated with keratinocyte proliferation and 478 
differentiation [80,83]. Some studies demonstrated enhanced JNK activity in psoriatic and 479 
wound-healing epidermal cells [84,85], as well as in cylindromas and other hair follicle 480 
derived tumors [86]. Moreover, experiments using animal or human tissue samples suggested 481 
that the JNK-Ap1 signalling pathway has an important role in development of squamous cell 482 
carcinoma and melanoma [86]. It is also possible that CPDs (or other UV-induced DNA-483 
lesions) formed in the promoter or enhancer region of genes alter binding potentials of 484 
transcription factor leading to change in gene expression [87,88]. These published data raise 485 
the question whether expression of certain genes can be changed directly by UV-induced 486 
CPDs formed in their promoter region rather than through a damage-response signalling 487 
pathway. The answer to this question should come from studies with systematic investigation 488 
using specific inhibitors of signalling pathways to prove that indeed the observed 489 
transcriptional changes is mediated through a CPD-dependent signalling event or caused by a 490 
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change in the promoter. Studies are ongoing to discern the mechanisms of CPD photolesion-491 
mediated activation of JNK and its downstream effectors. 492 
Conclusion 493 
In vitro-transcribed mRNA can be easily generated and it is a new platform for the delivery of 494 
We demonstrated that in vitro-transcribed mRNA encoding non-human CPD-photolyase can 495 
efficiently be translated into a functional protein in cultured human keratinocytes. Using 496 
pseudouridine-modified mRNA encoding CPD-specific photolyase, which can specifically 497 
remove UVB-induced CPD lesions after exposure to photoreactivating light, we found that 498 
the CPD lesions represents the major contributors to the transcriptional response to UVB 499 
irradiation. Network analysis of CPD-regulated genes revealed that CPDs are principal 500 
mediators of biological processes related to cell cycle signalling and transcriptional control. 501 
Consequently, the presence of CPDs modulated the transcription profile of many genes that 502 
are involved in the regulation of cell cycle (e.g. CCNE1, CDKN2B) or function as 503 
transcription factors (e.g. ATF3, ID2, RUNX1). Taken together, the results presented here 504 
demonstrates that an approach based on transfection of in vitro-transcribed mRNA is suitable 505 
for distinguishing UVB-induced CPD-dependent and -independent cellular mechanisms, and 506 
explore the molecular details of the involved signalling pathways. 507 
therapeutic proteins opening wide perspectives for dermatological or other medical 508 
utilizations. This novel mRNA-based model provides an opportunity to identify additional 509 
UV-specific molecular targets and achieve a better understanding of UVB-mediated skin 510 
diseases. 511 
We demonstrated that nucleoside-modified mRNA encoding non-human CPD-photolyase 512 
can efficiently be translated into a functional protein in cultured human keratinocytes. In 513 
vitro-transcribed mRNA is commercially available and is a new platform for the delivery of 514 
therapeutic proteins opening wide perspectives for dermatological or other medical 515 
23 
 
utilizations. We also demonstrated that our mRNA-based model is suitable for investigating 516 
CPD-dependent cellular functions and provides an opportunity to identify novel UV-specific 517 
molecular targets and achieve a better understanding of UVB-mediated skin diseases. 518 
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 Figure legends 739 
Figure 1. Accelerated photorepair of CPDs in HaCaT cells transfected with CPD-PL Ψ-740 
mRNA. HaCaT cells were transfected with lipofectamine-complexed Ψ-mRNA encoding 741 
CPD-photolyase. Twelve hours later, cells were subjected to 20 mJ/cm2 UVB and 742 
immediately exposed to photoreactivating light (photoreactivated) or left in the dark (non-743 
photoreactivated) for 1 h and then maintained at 37°C for 5 and 23 hs. After incubation at 5 744 
and 23 h, genomic DNA was isolated at the indicated times after UVB irradiation and the 745 
amount of CPDs was measured by ELISA. The values were calculated relative to those 746 
obtained with cells that were not UVB-irradiated. Significance was assessed by unpaired, 747 
two-sample t-test, p<0.05. Error bars represent the standard error of the mean from three 748 
experiments performed independently. 749 
Figure 2. Experimental verification of microarray results for 9 selected genes. HaCaT 750 
cells were exposed to 20 mJ/cm2 UVB at 12 h after delivery of CPD-PL Ψ-mRNA. 751 
Immediately thereafter, cells were either subjected to photoreactivating light (active CPD-752 
photolyase) or left in the dark (inactive CPD-photolyase) for 1 h. Following incubation total 753 
RNA was extracted at 5 and 23 h, then real-time RT-qPCR was performed to validate the 754 
CPD-dependent expression of ATF3, CCNE1, CDKN2B, EGR1, ID2, PTGS2, RUNX1, 755 
SNAI1 and SNAI2. Values measured in UVB irradiated cells with or without  756 
photoreactivation were related to those measured in non-UVB irradiated cells that were 757 
transfected control Ψ-mRNA, (pecked lines). Asterisks indicate significant differences (two-758 
tailed, unpaired t-test; p<0.05) between photoreactivated (active CPD-photolyase) and non-759 
photoreactivated (inactive CPD-photolyase) samples. The results of RT-qPCR are means  760 
SEM from three independent experiments in triplicate. 761 
Figure 3. Photorepair of CPDs prevents altered expression of cyclin E1 and p15INK4b 762 
protein in UVB irradiated HaCaT cells. Cells were transfected with lipofectamine-763 
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complexed CPD-PL Ψ-mRNA, 12 hs later irradiated with 20 mJ/cm2 UVB and immediately 764 
exposed to photoreactivating light (active CPD-photolyase) or kept in the dark (inactive CPD-765 
photolyase) for 1 h. Subsequently, cells were cultured at 37°C until harvested at the indicated 766 
time after UVB irradiation. (A) The expression of cyclin E1 and p15INK4b were analyzed by 767 
Western blot. (B) Quantitation of western blots displays relative changes in protein expression 768 
normalized to β-actin. Pixel densities were calculated relative to those obtained with cells that 769 
were not UVB irradiated (pecked lines). Significance was assessed by two-tailed, unpaired t-770 
test (asterisk, p<0.05) showing differences between photoreactivated and non-771 
photoreactivated samples. Error bars represent the standard error of the mean. The results are 772 
means of three independent experiments. 773 
Figure 4. Induction of cyclin E1 and p15INK4b protein expression upon UVB exposure 774 
is regulated through the JNK signalling pathway in HaCaT cells. Keratinocytes 775 
transfected with CPD-PL Ψ-mRNA were incubated in serum-free medium supplemented with 776 
JNK inhibitor (SP600125) for 1 h. Immediately thereafter, cells were irradiated with a 777 
physiological dose of UVB or left untreated followed by exposure to photoreactivating light 778 
(or not) for 1 h. The cells were cultured further in serum-free medium supplemented with the 779 
inhibitor. Cells were harvested for western blot assay at the indicated time. Protein levels of 780 
cyclin E1, p15INK4b, and β-actin are noted. The figure shows representative results from 781 
three independent experiments. 782 
Supporting information 783 
S1 Table. List of all up and downregulated genes related to CPD lesions determined in 784 
CPD-PL -mRNA transfected human keratinocytes at 6 h after UVB exposure by 785 
microarray analyses. 786 
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S2 Table. List of all up and downregulated genes related to CPD lesions determined in 787 
CPD-PL -mRNA transfected human keratinocytes at 24 h after UVB exposure by 788 
microarray analyses. 789 
S1 Fig. Divergence of UVB-mediated gene expression changes using CPD-specific 790 
photolyase encoded by in vitro-transcribed mRNA. To characterize the expression profile 791 
of CPD-related genes, oligonucleotide microarray was carried out as described in Materials 792 
and Methods. Bar graph represents the total number of UVB-responsive genes determined 6 793 
and 24 h after the exposure. Bioset was divided into CPD-independent (the presence of active 794 
photolyase had no effect on the expression level of genes modified by UVB irradiation) and 795 
CPD-dependent (the presence of active photolyase has restored the expression level of genes 796 
modified by UVB irradiation) genes. Cut-off values for changes in gene expression were set 797 
at  2-fold. 798 
S2 Fig.  Top network interactions among CPD-dependent genes determined at 6 and 24 799 
h after UVB irradiation in CPD-PL -mRNA transfected keratinocytes. To analyze 800 
network interactions of CPD-dependent genes, datasets representing differentially regulated 801 
genes derived from microarray were imported into the Ingenuity Pathway Analysis (IPA) 802 
application. The list of the top three networks and associated cellular functions of all CPD-803 
related gene datasets are shown with their respective scores and p-values (p < 0.05) obtained 804 
from IPA (panel A). The score is derived from a p-value and indicates the likelihood of the 805 
focus genes in a network being found together due to random chance (defined as: - log10 (p-806 
value)). The most highly rated networks of genes, determined 6 (panel B) and 24 h (panel C) 807 
after UVB irradiation, are illustrated with the significantly up- (red shaded) and 808 
downregulated (green shaded) genes modulated in a CPD-dependent manner. Genes in empty 809 
nodes were not identified as differentially expressed in our experiment and were generated 810 
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automatically by IPA Knowledge Base indicating a relevance to this network. The genes 811 
marked with blue circle have been validated by RT-qPCR. 812 
S3 Fig. Functional classification of CPD-related genes belonging to top rated networks 813 
determined by IPA. To analyze functional classification of CPD-responsive genes belonging 814 
to top networks, datasets derived from the results of network analysis were imported into the 815 
Database for Annotation, Visualization and Integrated Discovery (DAVID) tool. The list of 816 
these CPD-dependent genes, determined at 6 and 24 h after UVB irradiation is shown 817 
according to their cellular functions (panel A-G). Gene expression values measured in 818 
photolyase mRNA transfected and UVB irradiated cells (PL+UVB) were compared to those 819 
measured in non-UVB irradiated control cells, while photolyase mRNA transfected, UVB-820 
irradiated and photoreactivated samples (active CPD-photolyase) were compared to those that 821 
were photolyase mRNA transfected and UVB irradiated, but left without photoreactivation 822 
(inactive CPD-photolyase). Cut-off values for changes in gene expression were set at  2-fold. 823 
To evaluate statistical analysis unpaired, Student’s t-test followed by Benjamini-Hochberg 824 
corrections were used. The genes marked with red boxes were selected for further 825 
investigation. The blue box in (F) represents a gene (IL6) that was confirmed in previous 826 
work [19] to have CPD-dependent changes in expression. 827 
Responses to the comments of Reviewer 1 
Dear Reviewer, 
Thank you for your thoughtful and constructive comments. 
We addressed all your comments and further experimentation was performed, according to 
your advice. 
Specifically: 
Comment 1. The paper would be much strengthened by further experiments directly 
addressing JNK in mediating CPD effects (e.g. inhibit JNK and then determine photolyase 
effect with and without UV), without this critical experiment, the manuscript is, in my 
opinion, too correlative. 
We agree with your assertion and carried out the proposed experiment. The results are 
included into the revised Figure 4 (see lines 330-340, on page 15 of the revised manuscript). 
Comment 2. Is it possible that certain genes (e.g. their promoters or enhancers) may be 
particularly vulnerable to UV-induced CPD formation? If so, then these genes may be down-
regulated directly by UV rather than through a damage-response pathway such as JNK. 
(alternatively a gene's expression might be upregulated if an inhibitory gene's expression were 
CPD-prone). 
We agree that regulatory regions of selected genes might be directly vulnarable to UVB, 
therefore we included this potential in the manuscript and added background material to the 
revised manuscript and propounded an experimental procedure to appropriately support this 
issue (see lines 483-491, on pages 21-22 of the revised manuscript). 
Comment 3. It seems odd that the figure legends are embedded right in the text rather than 
as a separate section. 
Response to Reviewers
We corrected this error. The figure legends are now in a separate section at the end of the 
revised manuscript. 
Comment 4. Do the data exclude a role for gene regulation by 6,4-photoproducts? 
We have added a new section to the revised manuscript in which we provide additional 
information related to the contribution of 6-4 photoproducts to UVB-induced changes of gene 
expression (see lines 368-379, on page 17 of the revised manuscript). 
Comment 5. The role of p53 should also be examined in CPD-induced gene expression 
changes. 
We agree, so we have inserted background material to provide additional information about 
the role of p53 in UVB-induced cellular stress responses (see lines 395-404, on page 18 of the 
revised manuscript). 
Response to the comment of Reviewer 2 
Dear Reviewer, 
We appreciate your comment and following your suggestion we prepared a separate 
conclusion section. 
Comment 1. The major short-coming, which is mostly editorial, is coming from the lack of 
a separate conclusion section. The last paragraph, which effectively serves as a conclusion, 
needs to be expanded and be placed in line with the abstract. 
We have added a separate conclusion section to provide additional context to the revised 
manuscript (see lines 493-511, on page 22 of the revised manuscript). 
